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SUMMARY 
Salmonella Typhimurium (S. Typhimurium) is a Gram-negative, facultative 
intracellular bacterium that exploits the host’s type I interferon (IFN-I) response to induce cell 
death in macrophages. We have previously demonstrated that activation of the IFN-I receptor 
(Ifnar1) results in recruitment of RIP1 and subsequent formation of a RIP1/RIP3 complex, 
leading to a specific form of programmed cell death, termed necroptosis, in S. Typhimurium-
infected macrophages (Robinson et al. 2012). Despite our detailed knowledge on IFN-
I/RIP1/RIP3-dependent necroptosis execution, the IFN-I-mediated pathways that determine 
whether infected macrophages will undergo necroptosis remain elusive. This work therefore 
sought to identify the IFN-I-mediated events that sensitize S. Typhimurium-infected 
macrophages to cell death. 
Here, we demonstrate that S. Typhimurium infection causes mitochondrial damage 
and impairs the host´s anti-oxidative stress response through upregulation of the 
mitochondrial phosphatase Pgam5 downstream of IFN-I/RIP3. Pgam5 subsequently interacts 
with the transcription factor Nrf2, which sequesters Nrf2 in the cytosol thereby repressing the 
transcription of Nrf2-dependent anti-oxidative genes. The impaired ability to respond to 
S. Typhimurium-induced oxidative stress results in ROS-mediated mitochondrial damage, 
ATP depletion, transient induction of autophagy, and autophagy-mediated degradation of 
p62, which impairs p62-Keap1 interaction. Consequently, Keap1 interacts more with Nrf2, 
which further represses Nrf2 function and additionally impairs anti-oxidative stress responses 
to S. Typhimurium infection thereby sensitizing macrophages to cell death.  
Taken together, we identify impaired Nrf2-dependent redox homeostasis of 
S. Typhimurium-infected macrophages as an important mechanism that drives cell death 
downstream of IFN-I/RIP3.  
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ZUSAMMENFASSUNG 
Salmonella Typhimurium (S. Typhimurium) ist ein Gram-negatives, fakultativ intrazelluläres 
Bakterium, welches die Typ-I-Interferon (IFN-I)-Antwort des Wirts ausnutzt, um den Zelltod in 
Makrophagen zu induzieren. Unsere Vorarbeiten zeigen, dass die Aktivierung des IFN-I-
Rezeptors (Ifnar1) zur Rekrutierung von RIP1 und zur anschließenden Bildung eines 
RIP1/RIP3-Komplexes führt, was zu einer bestimmten Form des programmierten Zelltods, 
der sogenannten Nekroptose, in mit S. Typhimurium infizierten Makrophagen führt (Robinson 
et al. 2012). Trotz unseres detaillierten Wissens über die Mechanismen der IFN-I/RIP1/RIP3-
abhängigen Nekroptose sind die durch IFN-I vermittelten Signalwege, die darüber 
bestimmen, ob infizierte Makrophagen ihr Nekroptose Programm ausführen, weiterhin unklar. 
Ziel dieser Arbeit ist es daher, die durch IFN-I vermittelten Ereignisse zu identifizieren, die mit 
S. Typhimurium infizierte Makrophagen für den Zelltod sensibilisieren. 
Unsere Ergebnisse zeigen, dass die Infektion mit S. Typhimurium eine Schädigung der 
Mitochondrien verursacht und die anti-oxidative Stressreaktion des Wirts beeinträchtigt, 
indem die mitochondriale Phosphatase Pgam5, welche IFN-I/RIP3 nachgeschaltet ist, 
hochreguliert wird. Pgam5 interagiert anschließend mit dem Transkriptionsfaktor Nrf2, 
wodurch Nrf2 im Cytosol sequestriert und die Transkription von Nrf2-abhängigen anti-
oxidativen Genen beeinträchtigt wird. Die eingeschränkte Fähigkeit auf S. Typhimurium-
induzierten oxidativen Stress zu reagieren, führt zur ROS-vermittelten Schädigung von 
Mitochondrien, einem ATP Mangel, der vorübergehenden Induktion von Autophagie und der 
autophagievermittelten Degradation von p62, welches die p62-Keap1-Interaktion 
beeinträchtigt. Folglich interagiert Keap1 vermehrt mit Nrf2, wodurch die Funktion von Nrf2 
weiter eingeschränkt wird und die anti-oxidative Stressantwort gegen S. Typhimurium 
zusätzlich beeinträchtigt wird, wodurch Makrophagen für den Zelltod sensibilisiert werden. 
Zusammenfassend haben wir die gestörte Nrf2-abhängige Redox-Homöostase als einen 
wichtigen Mechanismus identifiziert, der den Zelltod von mit S. Typhimurium infizierten 
Makrophagen stromabwärts von IFN-I/RIP3 vermittelt. 
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ABBREVIATIONS 
AREs Antioxidant response elements 
Atg7-/- Autophagy-related protein 7 deficient macrophages 
ATP Adenosine triphosphate 
BMDMs Bone marrow-derived macrophages  
CFUs Colony forming units 
ConcA Concanamycin A 
Ctrl Control  
Drp1 Dynamin-related protein 1 
Gapdh Glyceraldehyde 3-phosphate dehydrogenase 
Gclc Glutathione synthesis enzyme glutamate cysteine ligase 
Hmox-1 Heme oxygenase-1 
IFN-I  Type I interferon 
IFN-β Interferon beta 
Ifnar1-/- Type I interferon receptor deficient macrophages 
IgG Immunoglobulin G 
Keap1 Kelch-like ECH-associated protein 1 
LC3 Microtubule-associated proteins 1A/1B light chain 3B 
LDH Lactate dehydrogenase 
LPS Lipopolysaccharide 
MFI Mean fluorescence intensity 
MLKL Mixed lineage kinase domain-like protein 
MOI Multiplicity of infection 
mRNA Messenger RNA 
mTORC1 Mechanistic target of rapamycin complex 1 
mtROS Mitochondrial reactive oxygen species 
Ψm Mitochondrial membrane potential  
Nqo1 NAD(P)H quinone oxidoreductase 1 
Nrf2 Nuclear factor (erythroid-derived 2)-like 2 
OCR Oxygen consumption rate 
Pgam5 Phosphoglycerate mutases family member 5 
p.i. Post infection 
RIP3 Receptor-interacting protein kinase 3 
RIP3-/- Receptor-interacting protein kinase 3 deficient macrophages 
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ROS Reactive oxygen species 
S.  Salmonella 
SCV Salmonella containing vacuole 
SD Standard deviation 
SPI Salmonella pathogenicity island 
Sqstm1/p62 Sequestosome-1 
ST Salmonella Typhimurium 
S6K S6 kinase 
TLR Toll like receptor 
TMRM Tetramethylrhodamine methyl ester 
TNF Tumor necrosis factor 
Tom20 Translocase of outer membrane subunit 20 
T3SS Type 3 secretion system 
UI Uninfected 
WT Wildtype 
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1. Introduction 
1.1 Salmonella Typhimurium infection 
1.1.1 Microbiology and epidemiology of S. Typhimurium  
Salmonellae are Gram-negative, rodshaped bacteria that infect or colonize a wide 
range of mammalian hosts worldwide. Salmonellae are motile, facultative intracellular and 
facultative anaerobe bacteria that belong to the large family of Enterobacteriaceae. The 
genus Salmonella consists of two species, Salmonella enterica and Salmonella bongori. 
Salmonella enterica is further divided into six different subspecies. In total, about 2,500 
different Salmonella serotypes have been identified with most of the clinically relevant 
serotypes belonging to subspecies I (Salmonella enterica, subspecies enterica) (Tindall et al. 
2005).  
Humans infected with Salmonella typically present with symptoms of gastroenteritis 
or typhoid fever (systemic infection with fever and abdominal symptoms). Gastroenteritis can 
be caused by numerous different Salmonella serotypes (~ 500 serotypes) that are collectively 
known as nontyphoidal Salmonellae (NTS), whereas typhoid fever is predominantly caused 
by Salmonella enterica serovar Typhi and Paratyphi (Robert Koch Institute 2019). The global 
burden of NTS gastroenteritis has been estimated at about 94 million cases and 155,000 
deaths per year (Majowicz et al. 2010). In Germany, more than 12,000 cases of NTS were 
reported in 2018 according to the Robert Koch Institute (Robert Koch Institute 2019). Children 
below the age of five years, elderly people and patients with immunosuppression are more 
susceptible to Salmonella infection (Ryan and Ray 2004). Among NTS, Salmonella enterica 
serovar Enteritidis (S. Enteritidis) and Salmonella enterica serovar Typhimurium 
(S. Typhimurium) are of particular interest, as they are the most commonly isolated serotypes 
worldwide (Lan et al. 2009; World Health Organisation 2019).  
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1.1.2 Pathogenesis of S. Typhimurium  
S. Typhimurium infection is usually acquired by oral ingesting of contaminated food, 
such as dairy products, eggs or meat. Approximately 104 to 106 bacteria are sufficient to cause 
infection in humans (Robert Koch Institute 2019). After overcoming gastric acidity, 
S. Typhimurium penetrates the epithelial barrier of the small intestine (Fig. 1). It actively 
invades intestinal epithelial cells or it induces its phagocytic uptake by microfold cells (M cells) 
that overlie the lymphoid follicles of Peyer's patches (Jones et al. 1994). In humans, 
S. Typhimurium infection usually does not proceed beyond the lamina propia. In mice and 
immunocompromised patients, however, S. Typhimurium gains access to the basolateral 
side of the intestine, where it is sensed and phagocytosed by monocytic-derived cells of the 
gut-associated lymphatic tissue (GALT), predominantly macrophages and dendritic cells 
(Broz et al. 2012). In susceptible hosts, S. Typhimurium enters the lymphatic system and the 
bloodstream via infected monocytes, allowing S. Typhimurium to spread to the liver and the 
spleen thereby establishing systemic infection (Vazquez-Torres et al. 1999). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic representation of S. Typhimurium invading the intestinal mucosa.  
(1) The major route of Salmonella invasion is via transcytosis through M cells at the Peyer´s Patches followed by 
(2) Salmonella pathogenicity island 1 (SPI-1)-mediated invasion of enterocytes. Alternatively, (3) Salmonella can 
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also be taken up by CX3CR+ macrophages or dendritic cells (DCs) located at the basolateral intestinal side. Figure 
taken from (Broz et al. 2012). 
 
Following epithelial cell invasion or phagocytic uptake, S. Typhimurium is engulfed in 
a membrane‐derived compartment called Salmonella‐containing vacuole (SCV) (Bakowski et 
al. 2008). In a strict sense, SCVs are only formed in epithelial cells, whereas in professional 
phagocytes S. Typhimurium is taken up by phagosomes. SCVs show certain characteristics 
of late stage endosomes and express lysosomal markers that include lysosome-associated 
membrane proteins (LAMPs), the GTPase Rab7 and vacuolar ATPases (LaRock et al. 2015). 
However, further maturation of the SCV does not occur as S. Typhimurium actively inhibits 
SCV fusion with the lysosome thereby preventing its enzymatic degradation (LaRock et al. 
2015). The ability of S. Typhimurium to persist in host cells, including macrophages, is crucial 
for its pathogenesis, as strains lacking this ability are non-virulent (Bakowski et al. 2008). 
S. Typhimurium virulence is highly dependent on the expression of two distinct type 
III secretion systems (T3SSs) and several effector proteins that are encoded on large 
chromosomal clusters termed Salmonella pathogenicity island 1 (SPI‐1) and SPI‐2. The T3SS 
apparatus, which is highly conserved among Gram-negative bacteria, forms a needle-like 
complex that mediates the injection of bacterial translocon and effector proteins into the host 
cell`s cytoplasm (Aizawa 2001). SPI-1-encoded T3SS effector proteins, such as SipA, SopB 
and SopE, are essential for epithelial invasion by inducing actin cytoskeleton rearrangements 
leading to membrane ruffling and subsequent uptake of S. Typhimurium (LaRock et al. 2015). 
A major function of the SPI‐2-encoded T3SS effector proteins, such as SifA and SsrB, is the 
modification of the SCV to enable intracellular survival and replication of S. Typhimurium 
within the inhospitable milieu of the SCV (Hensel et al. 1998).  
1.2  Interaction of S. Typhimurium with macrophages 
1.2.1 Activation of inflammatory pathways 
Once S. Typhimurium has passed the epithelial barrier of the small intestine, it is 
targeted by cells of the innate immune system, predominantly macrophages. Macrophages 
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sense S. Typhimurium through their pattern recognition receptors (PRRs), which mediate 
recognition of pathogen-associated molecular pattern molecules (PAMPs). Toll-like receptors 
(TLRs) function as the PRRs in mammals and play a major role in the defense against 
extracellular and intracellular S. Typhimurium. TLRs can be activated by a variety of 
S. Typhimurium-derived ligands, such as peptidoglycan and lipoproteins (TLR2), LPS (TLR4), 
flagellin (TLR5) and CpG-rich repeats of bacterial DNA (TLR9) (Broz et al. 2012). TLR 
activation engages the signaling adaptors MyD88 and TRIF that culminate in the activation 
of nuclear factor- κB (NF-κB) and interferon regulatory factor 3 (IRF3), which control the 
expression of several pro-inflammatory cytokines as well as type I interferon (IFN-I) 
(Medzhitov 2001). The induction of inflammatory signaling pathways is necessary for the 
generation of a robust antimicrobial milieu and for the proper activation of adaptive immune 
responses. 
1.2.2 Induction of oxidative stress  
 Reactive oxygen species (ROS) are essential components of the innate immune 
response against invading pathogens. Upon S. Typhimurium infection, ROS contribute to the 
efficient control of intracellular S. Typhimurium, as ROS increases the phagosomal 
bactericidal activity of macrophages (West et al. 2011). Macrophages have been shown to 
generate ROS through the phagosomal NADPH oxidase and the mitochondrial oxidative 
phosphorylation (OXPHOS) machinery (Lambeth 2004). ROS comprises oxygen free 
radicals, such as superoxide anion radical (O2·−) and hydroxyl radical (·OH), and non-radical 
oxidants, such as hydrogen peroxide (H2O2) and singlet oxygen (1O2), which can be 
interconverted from one to another (Zorov et al. 2014). The majority of mitochondrial ROS 
(mtROS) are derived from complex I or complex III of the electron transport chain (Murphy 
2009). Although mtROS have been recognized as important signaling hubs linking 
mitochondrial to cytoplasmic signals, extensive mtROS production results in oxidative DNA 
damage and cell death (Murphy 2009). Therefore, mtROS levels have to be tightly controlled 
by a versatile antioxidant system. 
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Nuclear factor-erythroid 2-related factor 2 (Nrf2) is a key transcription factor that 
neutralizes cellular ROS by inducing multiple genes whose products have anti-oxidative 
functions. Kelch-like ECH-associated protein 1 (Keap1), a redox regulated substrate adaptor 
for a cullin-based ubiquitin ligase, is the major negative regulator of Nrf2 (Lo and Hannink 
2008). Under resting conditions, Keap1 sequesters Nrf2 in the cytoplasm and mediates Nrf2 
ubiquitination and its subsequent degradation via the proteasomal pathway (Kobayashi et al. 
2004; Zhang et al. 2004). In response to oxidative stress, however, Nrf2 is released from 
Keap1 and translocated into the nucleus, where it binds to conserved antioxidant response 
elements (AREs) in the promoter regions of target genes, such as the detoxification enzyme 
NAD(P)H quinone oxidoreductase 1 (Nqo1), glutathione synthesis enzyme glutamate 
cysteine ligase (catalytic subunit, Gclc), and cell stress protein heme oxygenase-1 (Hmox-1) 
(Ishii et al. 2002; Rushmore et al. 1991; Wasserman and Fahl 1997).  
Nrf2 function is negatively regulated by the mitochondrial phosphatase Pgam5, which 
has originally been identified as a protein bound to Keap1 (Lo and Hannink 2006). Pgam5 
contains an N-terminal mitochondrial-localization sequence that mediates its recruitment to 
the outer mitochondrial membrane, where Pgam5 forms a ternary complex with Keap1 and 
Nrf2, in which the dimeric Keap1 simultaneously binds Pgam5 and Nrf2 (Lo and Hannink 
2008). Nrf2 is consequently sequestered in this inhibitory complex leading to impaired 
activation of Nrf2-dependent anti-oxidative genes. 
Recent studies suggest that the autophagy adaptor protein Sqstm1/p62 (hereafter, 
p62), is a positive regulator of the Nrf2 pathway. Upon oxidative stress, p62 directly interacts 
with the Nrf2-binding site of Keap1. Consequently, Nrf2 is released from Keap1 and 
translocated to the nucleus leading to the transcription of Nrf2-dependent anti-oxidative 
enzymes (Ichimura et al. 2013; Komatsu et al. 2010; Lau et al. 2010).  
1.2.3 Interference with autophagy  
Autophagy is a highly-conserved catabolic process that involves the complex interplay 
of more than 35 autophagy-related proteins (Atgs) allowing the enzymatic degradation of 
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large intracellular components, such as protein aggregates and long-lived or damaged 
organelles. Autophagy is usually induced by nutrient starvation through the inhibition of 
mammalian target of rapamycin complex 1 (mTORC1) leading to the engulfment of 
endogenous cargo into double-membrane vesicles called “autophagosomes”, which are 
subsequently degraded by the lysosomal pathway (Deretic et al. 2013; Mizushima et al. 
2008).  
Furthermore, autophagy is known to mediate the degradation of ubiquitinated cargo, 
such as misfolded proteins and protein complexes. Autophagy of ubiquitinated proteins 
requires the adaptor protein p62, which contains multiple protein-protein interaction sites, 
including a C-terminal ubiquitin-associated (UBA) domain and a LC3 interaction region (LIR). 
These domains allow p62 to bind simultaneously to ubiquitinated cargo and LC3 thereby 
targeting proteins and organelles for autophagosomal degradation (Bjorkoy et al. 2005; 
Itakura and Mizushima 2011; Pankiv et al. 2007). Beyond its importance for maintaining 
cellular energy and protein homeostasis, autophagy has also been shown to have more 
diverse functions, such as selective removal of proteins or clearance of intracellular 
pathogens (Sumpter and Levine 2010).  
Selective autophagy of invading pathogens (xenophagy) has been recognized as an 
important component of cell-autonomous immunity. While several studies underscore the 
importance of xenophagy during infection with Mycobacterim tuberculosis, Listeria 
monocytogenes, Shigella spp., and S. Typhimurium (Cemma and Brumell 2012), the exact 
mechanism by which intracellular bacteria are recognized by the autophagic machinery 
remain poorly understood. It has been suggested that approximately 25% of intracellular 
S. Typhimurium escape from the SCV following infection of HeLa cells (Birmingham et al. 
2006). Once in the cytosol, S. Typhimurium becomes coated with ubiquitin and associates 
with p62 and other adaptor proteins, such as nuclear dot protein 52 (NDP52), which mediate 
the LC3-dependent autophagic degradation of S. Typhimurium (Levine et al. 2011; Zheng et 
al. 2009). By contrast to epithelial cells, our recent work has demonstrated that xenophagy is 
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of minor relevance during S. Typhimurium infection of macrophages. While S. Typhimurium 
initially co-localizes with LC3-positive structures, it escapes from these structures during the 
further course of infection (Ganesan et al. 2017), indicating that it manipulates autophagy. 
Probably more important than targeting intracellular bacteria for autophagic 
degradation, is the interplay between autophagy and innate immune signaling pathways. 
Indeed, there is increasing evidence that engagement of TLR4 by LPS in macrophages 
induces autophagy through interaction of TRIF and MyD88 with the autophagy protein beclin-
1 (Shi and Kehrl 2008; Travassos et al. 2010). Furthermore, autophagy has been shown to 
fine-tune innate immune responses through modulation of IFN-I production and 
inflammasome activation (Sumpter and Levine 2010) as well as mediating cell death 
(Fitzwalter and Thorburn 2015).  
1.2.4 Induction of cell death  
For many years, apoptosis has been implicated as the major form of programmed cell 
death, whereas necrosis has mainly been considered as an accidental cell death process that 
occurs in response to different pathophysiological stimuli (Vanden Berghe et al. 2014). 
However, recent genetic evidence and the discovery of specific pharmacological inhibitors of 
necrosis have redefined necrosis as a highly regulated form of programmed cell death. 
Necrosis includes many different cell death modalities, such as necroptosis, ferroptosis, 
pyroptosis, and cell death associated with the release of (neutrophil) extracellular traps, called 
NETosis or ETosis (Pasparakis and Vandenabeele 2015).  
Among these, necroptosis is probably the most extensively studied form of necrosis. 
Necroptosis is a form of programmed cell death dependent on receptor-interacting Ser/Thr 
protein kinase (RIP) 1, RIP3 and its substrate mixed lineage kinase like (MLKL). Although 
many inflammatory signals, including TLR4 and IFN-I receptor activation as well as 
FAS/TRAIL signaling (Pasparakis and Vandenabeele 2015), can activate necroptotic 
pathways, the induction of necroptosis has been best exemplified by tumor necrosis factor 
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receptor (TNFR)-mediated signaling. Engagement of the TNFR induces the formation of a 
complex containing RIP1, RIP3, TNFR-associated death domain (TRADD), caspase-8, and 
FAS-associated protein with a death domain (FADD). While activation of caspase-8 results 
in apoptosis, inhibition of caspase-8, for instance by bacterial or viral proteins, triggers the 
formation of the necrosome. Autophosphorylation of RIP1 and RIP3 recruits the 
pseudokinase MLKL, which is itself phosphorylated by RIP3 leading to membrane 
permeabilization and subsequent cell death (Declercq et al. 2009). 
Despite our detailed knowledge on TNF-mediated necroptosis execution, the events 
pre-ceding necrosome formation remain less understood. Mitochondria have been 
recognized as important mediators of several cell death modalities (Galluzzi et al. 2012) and 
ATP depletion by mitochondrial damage has been shown to be a trigger for necrosis 
(Vanlangenakker et al. 2008). In response to infection, mitochondria can change from a 
source of energy into organelles that promote cell death by releasing mtROS and toxic 
proteins that are usually retained within the mitochondrial intermembrane space (Kroemer et 
al. 2007). Furthermore, the mitochondrial phosphatase Pgam5 has recently been implicated 
to mediate TNF-induced necroptosis. Mechanistically, Pgam5 is recruited to RIP1- and RIP3-
containing protein complexes at the outer mitochondrial membrane, where Pgam5 induces 
Drp1-mediated mitochondrial fragmentation resulting in necroptotic cell death (Wang et al. 
2012).  
The induction of cell death is a crucial virulence strategy employed by S. Typhimurium 
(Lindgren et al. 1996). Following invasion of host cells, S. Typhimurium requires the 
temporary niche of the SCV for intracellular adaption and replication, while at later stages of 
infection S. Typhimurium induces cell death to escape from the host cell and to infect 
surrounding cells.  In macrophages, S. Typhimurium was found to induce different cell death 
modalities, including apoptosis-like cell death requiring caspase-8 activation (Lindgren et al. 
1996), caspase-1/caspase-11-dependent pyroptosis resulting in IL-1β secretion (Brennan 
and Cookson 2000), and RIP3 and MLKL-dependent necroptosis via activation of IFN-I 
signaling pathways (Robinson et al. 2012). 
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1.3  Type I interferon (IFN-I)-dependent immune responses to S. Typhimurium  
1.3.1 Induction of IFN-I synthesis 
 IFN-I are immunomodulatory cytokines that are secreted by various mammalian cell 
types in response to viral and bacterial infection. The family of IFN-I consists of about 20 
members, with IFN-α and IFN-β being the major IFN-I expressed upon infection (Bogdan et 
al. 2004). Most of our knowledge on IFN-I signaling is derived from viral infection, but recent 
studies have also highlighted the importance of IFN-I for the cell-autonomous defense against 
bacterial infection (Bogdan et al. 2004).  
Following infection, IFN-I synthesis is predominantly induced through activation of the 
stimulator of interferon genes (STING) pathway. Pathogen-derived DNA is sensed in the 
cytosol by cyclic GMP–AMP synthase (cGAS), which induces the cyclic dinucleotide (CDN) 
second messenger cGAMP (cyclic GMP-AMP) to activate the signaling adaptor STING. 
STING together with TANK-binding kinase 1 (TBK1) is translocated to the perinuclear region, 
where TBK1 phosphorylates the transcription factor interferon regulatory factor 3 (IRF3). 
Subsequently, IRF3 translocates to the nucleus and induces the transcription of numerous 
innate immune genes, including IFN-β, the main IFN-I in mice (Barber 2015).  
Several bacteria have been shown to activate the STING pathway, such as Legionella 
pneumophila, Francisella tularensis, Streptococcus pyogenes, Brucella abortus and 
Mycobacterium tuberculosis (Barber 2015; Marinho et al. 2017). STING activation by 
S. Typhimurium, however, has not been reported to date (Marinho et al. 2017) and IFN-I 
production by S. Typhimurium is mainly thought to be mediated through LPS-mediated TLR4 
activation (Owen et al. 2016; Sing et al. 2000).Gram-negative infection or binding of LPS to 
TLR4 engages TIR-domain containing adaptor protein inducing IFN-β (TRIF) and TRIF-
related adaptor molecule (TRAM) (Yamamoto et al. 2003). This mediates activation of tank-
binding kinase 1 (TBK1) and the inhibitor of nuclear factor-κB kinase (IKK-i), which leads to 
dimerization and nuclear translocation of IRF3 resulting in the transcription of IFN-β and auto- 
and paracrine signal transduction through the IFN-I receptor (Decker et al. 2005). 
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1.3.2 Activation of the IFN-I receptor pathway 
IFN-I binds to a heterodimeric transmembrane receptor consisting of two subunits, 
IFN-I receptor (Ifnar) 1 and Ifnar2, respectively (Platanias 2005). Canonical Ifnar activation 
engages the receptor-associated protein tyrosine kinases Janus kinase 1 (JAK1) and tyrosine 
kinase 2 (TYK2), which phosphorylate the cytoplasmic transcription factors signal transducer 
and activator of transcription 1 (STAT1) and STAT2 (Stark and Darnell 2012). After 
dimerization and nuclear translocation, STAT1 and STAT2 form a complex with IRF9, which 
is termed IFN-stimulated gene factor 3 (ISGF3). ISGF3 subsequently binds to DNA 
sequences called IFN-stimulated response elements (ISREs), leading to the transcription of 
several hundred IFN-I stimulated genes (ISGs), which initiate antimicrobial pathways that limit 
the spread of infectious agents (Gough et al. 2012).  
1.3.3 IFN-I-mediated cell death  
Heterologous activation of the IFN-I pathways by various bacterial stimuli results in 
paradoxical infection outcomes, e.g. the production of IFN-I protects against some 
intracellular pathogens, such as Mycobacterium tuberculosis (Desvignes et al. 2012), while it 
enhances the susceptibility to other intracellular pathogens, such as Listeria monocytogenes 
(O'Connell et al. 2004). 
We have previously demonstrated that S. Typhimurium exploits the host´s IFN-I 
response to induce cell death within macrophages. Activation of the Ifnar1 lead to the 
recruitment of RIP1, promoting the formation of a RIP1-RIP3 complex, which mediated 
necroptosis of infected macrophages (Robinson et al. 2012). As a result, mice lacking the 
Ifnar1 (Ifnar1-/-) survived significantly better (~30 to 60 days), whereas wildtype (WT) mice 
died within seven days after S. Typhimurium infection (Fig. 2).  
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Figure 2. IFN-I-mediated necroptosis in S. Typhimurium-infected macrophages.  
Following infection of macrophages, S. Typhimurium induces TLR4-mediated transcription of IFN-I (predominantly 
IFN-β). IFN-I binds to its cognate receptor (IFNAR) in an autocrine manner. RIP1 is subsequently engaged to the 
IFNAR resulting in the formation of a RIP1/RIP3 containing complex that triggers necroptosis of infected 
macrophages. In bone marrow-derived macrophages, IFNAR signaling is required for TNF-mediated necroptosis. 
Figure taken from (Du et al. 2013). 
 
Importantly, better control of S. Typhimurium and enhanced survival of Ifnar1-/- mice 
was specifically mediated by macrophages, because macrophages of Ifnar1-/- mice increased 
survival when transferred into WT hosts (Robinson et al. 2012).  
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HYPOTHESIS 
Although our previous work has identified IFN-I-mediated activation of RIP1/RIP3 by 
S. Typhimurium as a novel pathway leading to necroptosis of macrophages, the mechanisms 
prior to necrosome formation largely remain unknown. We hypothesize that S. Typhimurium 
infection likely induces the same damage in WT and Ifnar1-/- macrophages. However, IFN-I 
signaling impairs the response to S. Typhimurium-induced damage in WT macrophages and 
the inability of WT macrophages to balance cellular homeostasis probably results in 
necroptosis execution. This work therefore aims to determine the harmful events mediated 
by IFN-I signaling that precede S. Typhimurium-induced cell death of macrophages. 
 
OBJECTIVES OF THIS WORK 
1.  To determine the role of IFN-I signaling upon S. Typhimurium infection of 
macrophages. 
2.  To unravel the harmful events mediated by IFN-I signaling leading to cell death of 
S. Typhimurium-infected macrophages. 
3.  To identify the IFN-I-dependent pathways resulting in cell death of S. Typhimurium-
infected macrophages. 
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2. Materials and Methods 
2.1 Materials 
2.1.1 List of instrumentation  
Instrumentation Company 
Countess II cell counter life technologies 
Curix60 developing machine  Agfa 
EM109 electron microscope  Zeiss 
Enspire multimode plate reader  PerkinElmer 
FACSCanto flow cytometer  BD Biosciences 
IX81 inverted confocal microscope Olympus  
PCR Cycler CFX96 Bio-Rad 
Seahorse XF-96 analyzer Agilent 
  
 
2.1.2  List of software 
Software Company 
FLOWJO v10.1  Tree Star 
Fluoview FV10-ASW v4.2 Olympus 
ImageJ  NIH 
Primer3web  v4.1.0 ELIXIR 
Prism v5  GraphPad 
 
2.1.3 List of chemicals and reagents  
Chemicals and reagents Company Cat. Number 
A/G agarose magnetic beads Merck Millipore 16-663 
Albumin Fraction V Carl Roth 8076.4 
BCA Protein Assay Kit  Pierce 23227 
CDDO Biomol Cay81035 
Cell Titer-Glo Luminescent Cell Viability Assay  Promega G7571 
CytoTox 96® Lactate Dehydrogenase Assay  Promega #G1780 
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Enhanced chemiluminescence (ECL) Western 
Blotting Detection Reagent 
GE Healthcare RPN2106 
Ethanol absolute Merck 100983 
Fetal bovine serum (FBS) Thermo Fisher 
Scientific 
10270-106 
Formaldehyde, 16% Thermo Fisher 
Scientific 
28908 
Gentamicin Life Technologies 15750037 
Glycerol Carl Roth 4626.4 
IL-1β ELISA kit R&D Systems DY401 
Image-iT® R FX signal enhancer Invitrogen I36933 
LEAF Purified anti-mouse IFN-β Antibody Biolegend 508104 
LEAF Purified Syrian Hamster IgG Isotype 
Control Antibody 
Biolegend 400916 
Lipofectamine 3000 transfection reagent Thermo Fisher 
Scientific 
L3000-008 
Methanol  Carl Roth 4627.6 
MitoSOX Mitochondrial ROS Detection Kit Thermo Fisher 
Scientific 
M36008 
NE-PER Nuclear and Cytoplasmic Extraction Kit Thermo Fisher 
Scientific 
78833 
Normal goat serum Life Technologies PCN5000 
Opti-MEM Reduced Serum Medium, GlutaMAX 
Supplement 
Thermo Fisher 
Scientific 
51985034 
Phosphate-buffered saline (PBS) Merck Millipore L1825 
ProLong Gold antifade containing DAPI Life Technologies P36935 
Protease & Phosphatase Inhibitor Cocktail Thermo Fisher 
Scientific 
1861280 
RNeasy Mini Kit  Qiagen 74106 
Seahorse XF Cell Mito Stress Test Kit Agilent 103015-100 
Sodium dodecyl sulfate (SDS) Carl Roth 0.183.3 
SsoFast EvaGreen Supermix Bio-Rad 1725201 
SuperScript III reverse transcriptase  Thermo Fisher 
Scientific 
18080-044 
Tetramethylrhodamine methyl ester (TMRM)  Thermo Fisher 
Scientific 
T-668 
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Trigonelline hydrochloride Merck T5509 
Tris-HCl Carl Roth 9090.2 
Triton X-100 Carl Roth 3051.3 
Trypan blue stain 0.4% Thermo Fisher 
Scientific 
15250061 
Tween 20 Carl Roth 9127.1 
VLE RPMI 1640 cell culture medium Merck Millipore FG1415 
 
2.1.4  List of antibodies 
Antibody Company Cat. Number 
Alexa Fluor 488 anti-mouse IgG  Invitrogen A-11017 
Alexa Fluor 488 anti-rabbit IgG  Invitrogen A-11008 
Alexa Fluor 594 anti-rabbit IgG  Invitrogen A-11072 
Anti-mouse IgG HRP-conjugated R&D Systems HAF007 
Anti-rabbit IgG HRP-conjugated  R&D Systems HAF008 
β-actin  Santa Cruz sc-47778 
GAPDH  Santa Cruz sc-47724 
Keap1  Proteintech 10503-2-AP 
Lamin B  Santa Cruz sc-374015 
LC3  Sigma Aldrich L7543 
MLKL  Santa Cruz sc-165025 
Nrf2  Santa Cruz sc-722 
p70 S6 kinase Cell Signaling 9202 
Pgam5  Abcam ab126534 
phospho-p70 S6 kinase Cell Signaling 9205 
phospho-MLKL  Abcam ab196436 
phospho-RIP3  Abcam ab195117 
RIP3  Santa Cruz sc-135171 
SQSTM1/p62  Cell Signaling 5114 
Tom20  Santa Cruz sc-17764 
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2.2 Methods 
2.2.1 Cell culture and bacterial infection 
Mice and generation of bone marrow-derived macrophages 
Bone marrow was extracted from 8 to 12 weeks old wildtype C57BL/6 (WT), type I 
interferon receptor (Ifnar1-/-), autophagy-related protein 7 (Atg7-/-) and receptor-interacting 
serine/threonine-protein kinase 3 (RIP3-/-) deficient mice. Bone marrow was differentiated into 
macrophages in RPMI medium supplemented with 10% of fetal bovine serum (FBS) and 20% 
of L929 cell culture supernatant for 7 days in a humidified incubator at 37°C and 5% CO2. 
Non-adherent cells were removed on days 3 and 5 and adherent bone marrow-derived 
macrophages (BMDMs) were used for experiments from day 7 to 9. All animal studies were 
performed according to institutional guidelines on animal welfare and were approved by the 
North Rhine-Westphalian State Agency for Nature, Environment, and Consumer Protection 
(Landesamt für Natur, Umwelt and Verbraucherschutz [LANUV] Nordrhein-Westfalen; File 
no: 84-02.05.40.14.082 and 84-02.04.2015.A443) and the animal care committee of the 
University of Cologne. 
S. Typhimurium infection of macrophages 
Salmonella enterica serovar Typhimurium (SL1344) was grown to the late-exponential 
phase in Brain Heart Infusion (BHI) broth at 37°C with constant agitation. Bacteria were then 
harvested, resuspended in 10% of sterile glycerol and aliquots were stored at -80°C until 
further use. For all experiments, BMDMs were infected with a multiplicity of infection (MOI) of 
10 for 10 min at room temperature and 30 min at 37°C. Subsequently, extracellular bacteria 
were removed by three times washing with RPMI medium containing 50 µg/ml gentamicin. 
Afterwards, infected BMDMs were incubated with RPMI medium containing 10% FBS and 
50 μg/ml gentamicin at 37°C. After 2 h of infection, gentamicin was diluted to 10 µg/ml for the 
remainder of the experiment. At the desired time points, BMDMs were washed once with PBS 
and samples were collected for experiments. 
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Bacterial colony formation assay  
BMDMs (0.5 x 106 cells/well) were seeded in 6-well plates 24 h prior to infection with 
S. Typhimurium. At 0 h and 24 h post infection, BMDMs were lysed with 1% Triton X-100 and 
0.01% SDS/PBS solution and samples were collected in 1.5 ml Eppendorf tubes. Lysates 
were serially diluted with sterile PBS and spread on BHI agar plates, which were incubated 
overnight at 37°C. The next day, colony forming units (CFUs) were counted to determine the 
number of intracellular bacteria.  
2.2.2 Protein and enzymatic assays 
Immunoblot analysis 
BMDMs (1.0-2.0 x 106 cells/well) were lysed with radio-immunoprecipitation assay 
(RIPA) buffer containing protease and phosphatase inhibitors and the protein amount of each 
sample was quantified using the BCA Protein Assay Kit according to the manufacturer`s 
instructions. Equal amounts of protein were mixed with SDS-PAGE sample loading buffer, 
boiled, resolved by SDS-PAGE and proteins were transferred to a PVDF membrane. Next, 
membranes were blocked with either 5% milk or 5% bovine serum albumin (BSA) in tris 
buffered saline (TBS) containing 0.05% Tween 20 (TBS-Tween) for 1 h at room temperature. 
Membranes were then incubated overnight at 4°C with primary antibodies against LC3, p70 
S6 kinase, phospho-p70 S6 kinase, SQSTM1/p62, Tom20, Nrf2, β-actin, Keap1, MLKL, 
phospho-MLKL, RIP3, phospho-RIP3, or Pgam5 diluted in TBS-Tween containing either 5% 
milk or 5% BSA. After three times washing with TBS-Tween, membranes were incubated with 
the appropriate secondary antibody conjugated to horseradish peroxidase (HRP) for 1 h at 
room temperature. Membranes were washed three times with TBS-Tween and incubated with 
an enhanced chemiluminescence (ECL) substrate for 1 min at room temperature and 
exposed to a X-ray film. X-ray films were automatically developed using the Curix60 machine 
(Agfa). Densitometric quantification of western blotting was performed using ImageJ software 
(NIH). 
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Immunoprecipitation  
BMDMs were plated in 10 cm dishes at 5.0 x 106 cells per dish 24 h before the 
experiment. BMDMs were infected with S. Typhimurium and samples were lysed with RIPA 
buffer containing protease and phosphatase inhibitors. After preclearing the cell lysate with 
protein A/G agarose magnetic beads for 1 h, beads were removed by placing the tube on a 
magnetic rack. The whole cell lysate (approximately 500 μg of protein) was incubated with 
4 µg of an antibody against Nrf2 overnight at 4°C. Protein A/G agarose beads were added 
again and incubated for an additional 1 h at room temperature. The immunoprecipitated 
proteins along with the agarose beads were collected by placing the tube on a magnetic rack. 
The collected beads were washed five times with RIPA buffer. Samples were mixed with 
SDS-PAGE sample loading buffer, boiled and resolved on a 10% SDS-polyacrylamide gel. 
The respective proteins precipitated were identified by immunoblot analysis. 
Subcellular fractionation analysis 
Nuclear fractions from BMDMs (1.0 x 106 cells/well) seeded in 6-well plates 24 h prior 
to infection were prepared using the NE-PER Nuclear and Cytoplasmic Extraction Kit 
according to the manufacturer’s instructions. Samples were subjected to SDS-PAGE and 
analyzed by immunoblotting with antibodies against Nrf2, Lamin B, or GAPDH. 
Enzyme-linked immunosorbent assay (ELISA) 
BMDMs (0.5-1.0 x 106 cells/well) were seeded in 6-well plates 24 h prior to infection. 
For ELISA, cell culture supernatants were collected 6 h and 24 h post infection and were kept 
at -80°C until assayed for mouse IL-1β according to manufacturer´s instructions. Absorbance 
was measured with a multimode plate reader at 450 nm (PerkinElmer). 
2.2.3 Mitochondrial and cell viability assays 
Mitochondrial ROS detection 
Mitochondrial reactive oxygen species (mtROS) were determined using MitoSOX 
according to the manufacturer´s instruction. BMDMs (0.5 x 106 cells/well) were seeded in 12-
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well plates 24 h prior to the experiment and were infected with S. Typhimurium for 6 h. 
Samples were subsequently fixed with 1% (wt/vol) formaldehyde in PBS for 10 min at room 
temperature and were then collected in FACS tubes. Fluorescence intensity of 50,000 cells 
per sample was analyzed by gating on live cells using the BD FACSCanto flow cytometer and 
FLOWJO software (Tree Star). The fluorescence intensity of BMDMs treated with MitoSOX 
was normalized to the intensity of BMDMs without MitoSOX treatment. 
Measurement of mitochondrial membrane potential 
Mitochondrial membrane potential (Ψm) was analyzed by TMRM staining, which is a 
fluorescent dye that accumulates in active mitochondria with intact mitochondrial membrane 
potentials. BMDMs (0.5 x 106 cells/well) were seeded in 12-well plates 24 h prior to the 
experiment and BMDMs were subsequently infected with S. Typhimurium. After 6 h of 
infection, medium was exchanged to fresh RPMI medium containing 10% FBS and 10 µM of 
TMRM. BMDMs were incubated with TMRM for 10 min at room temperature. Next, cells were 
washed three times with PBS, samples were fixed with 1% (wt/vol) formaldehyde in PBS for 
10 min at room temperature and were then collected in FACS tubes. Fluorescence intensity 
of 50,000 cells per sample was analyzed by gating on live cells using the BD FACSCanto 
flow cytometer and FLOWJO software (Tree Star). The fluorescence intensity of BMDMs 
treated with TMRM was normalized to the intensity of BMDMs without TMRM treatment. 
Seahorse assay 
Oxygen consumption rate (OCR) was analyzed using the Seahorse XF Cell Mito 
Stress Test Kit according to manufacturer’s instruction. Briefly, BMDMs were seeded at 0.2 x 
105 cells/well in a 96-well Seahorse plate 24 h before the experiment. A utility plate containing 
equilibration solution was placed in a CO2-free incubator at 37°C overnight. The following 
day, media was removed and cells were infected with S. Typhimurium as described before. 
After 2 h of infection, medium was replaced with glucose, glutamine and sodium pyruvate-
supplemented XF assay buffer and the plate was placed in a CO2-free incubator for at least 
30 min. Inhibitors (Oligomycin, carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone 
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[FCCP], 2-Deoxy-D-glucose [2DG], Rotenone) were added to the appropriate port of the 
injector plate. After calibration with the utility plate, the sample plate was run on the Seahorse 
XF-96 machine. 
ATP measurement  
BMDMs were seeded at 0.1 x 106 cells/well in a 96-well plate 24 h before infection 
with S. Typhimurium. After 2 h and 6 h of infection, ATP levels were determined using the 
Cell Titer-Glo Luminescent Cell Viability Assay according to manufacturer’s instructions. 
Luminescence was measured with a multimode plate reader (PerkinElmer). 
Cell viability assay 
BMDMs were seeded into a 96-well plate at 0.1 x 106 cells/well 24 h prior to the 
experiment. BMDMs were infected with S. Typhimurium and cell viability was measured at 
2 h and 6 h post infection using the CytoTox 96® Lactate Dehydrogenase Assay (LDH) 
according to the manufacturer’s instructions. Luminescence was determined with a 
multimode plate reader (PerkinElmer).  
2.2.4 Microscopic analyses 
Immunofluorescent staining and confocal microscopy 
BMDMs (0.1 x 106 cells/well) were seeded in 24-well plates containing 12 mm round 
coverslips 24 h before infection. After infection with S. Typhimurium, BMDMs were fixed with 
4% (wt/vol) formaldehyde in PBS for 15 min at room temperature. BMDMs were washed with 
PBS and permeabilized with 0.3% Triton X-100 in PBS for 5 min at room temperature. Next, 
BMDMs were washed with 0.03% Triton X-100 in PBS followed by incubation with Image-iT® 
R FX signal enhancer for 30 min and blocking with 5% BSA, 5% normal goat serum and 
0.03% Triton X-100 in PBS (blocking buffer) for 1 h at room temperature. After washing with 
0.03% Triton X-100 in PBS, BMDMs were incubated overnight at 4°C with primary antibodies 
against SQSTM1/p62, Tom20, Nrf2, Keap1, or Pgam5 diluted in blocking buffer. BMDMs 
were then washed three times with 0.03% Triton X-100 in PBS and incubated with appropriate 
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fluorescent secondary antibodies diluted in blocking buffer for 1 h at room temperature. After 
three times washing with 0.03% Triton X-100 in PBS, coverslips were mounted on glass slides 
using ProLong® Gold antifade containing DAPI and stored at 4°C until image acquisition. 
Images were acquired with a 60X oil PlanApo objective, numerical aperture 1.4 at room 
temperature on an Olympus IX81 inverted confocal microscope equipped with PMT detectors 
for imaging. Olympus Fluoview FV10-ASW 4.2 software was used for acquisition and 
calculating Pearson’s correlation. 
Electron microscopy 
BMDMs (1.5 x 106 cells/well) were fixed (2.5% glutardehyde, 2.5% sucrose, 3 mM 
calcium chloride, 100 mM HEPES, pH 7.4) for 1 h at room temperature. After washing with 
0.1 M cacodylate buffer (pH 7.2), cells were scraped and collected in cacodylate buffer. Cells 
were centrifuged (5 min, 500 x g, room temperature) and resuspended in 500 µl of warm 3% 
low melting agarose (diluted in cacodylate buffer). Cell suspension was transferred into a 
sealed 1 ml tip, placed into a 15 ml falcon tube and centrifuged at 1.500 x g for 10 min at 
room temperature to concentrate cells. The agarose pellet was removed from the tip and 
collected into 0.1 M cacodylate buffer. After fixation, cells were dehydrated in graded ethanol 
series (50%, 70%, 90%, 100%) for 3 min each and were then incubated with ethanol and 
propylenoxid. Next, cells were embedded using Epon medium. Sections were cut at a 
thickness of 70 nm (Ultracut UC6, Leica), stained with 1.5% aqueous uranyl acetate for 15 
min at 37°C and contrasted using lead nitrate solution. Samples were examined with an 
EM109 electron microscope (Zeiss) and images were recorded at 7,000 x or 50,000 x 
magnification. 
2.2.5 mRNA assays  
Transfection experiments 
BMDMs (1.0 x 106 cells/well) were seeded in a 6-well plate 24 h prior to transfection 
and were incubated with either 50 nM of non-targeting siRNA (#SR-CL000-005, Eurogentec) 
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or 50 nM of siRNA specific for Nfe2I2 (Nrf2; #L-040766-00-0005, Dharmacon), Sqstm1 (p62; 
#L-047628-01-0005, Dharmacon), or Pgam5 (#L-052506-01-0005, Dharmacon) together with 
the transfection reagent Lipofectamine 3000 according to manufacturer’s instructions. Briefly, 
for each well 0.5 µl of siRNA (100 µM) was diluted in 50 µl of Opti-MEM medium and was 
added to 4 µl of Lipofectamine transfection reagent diluted in 50 µl of Opti-MEM medium. 
Samples were gently mixed and incubated for 10 min at room temperature.  Next, 100 µl of 
the transfection mix was added drop by drop to each well, which contained 900 µl of RPMI 
medium supplemented with 10% of FBS. After 5 to 6 h of incubation at 37°C, the medium 
was exchanged to RPMI containing 10% of FBS. At 48 h post transfection, BMDMs were 
infected with S. Typhimurium. Knockdown efficiency was individually assessed by 
immunoblot analyses using antibodies against Nrf2, p62, or Pgam5. 
Quantitative real-time PCR (qRT-PCR)  
Total RNA from BMDMs (1.0 x 106 cells/well) was isolated by RNeasy Mini Kit and 
cDNA (500 ng) was synthesized with random hexamers using reverse transcriptase 
(SuperScript III). Primers were designed using Primer3 software and Basic Local Alignment 
Search Tool (National Center for Biotechnology Information, Bethesda, MD). PCR reactions 
(25 µL) contained 10 ng of cDNA, 0.4 µmol/L of each forward and reverse primer, and master 
mix (SsoFast EvaGreen Supermix). Real-time PCR was performed on a PCR Cycler CFX96 
(Bio-Rad) under the following conditions: initial denaturation step of 95°C for 2 min, 40 cycles 
of 95°C for 5 sec and 60°C for 15 sec, followed by a denaturation step of 95°C for 60 sec and 
subsequent melt curve analysis to check amplification specificity. Results were analyzed by 
the comparative threshold cycle method with hypoxanthine-guanine 
phosphoribosyltransferase (Hprt) as the endogenous reference gene for all reactions. The 
relative mRNA levels of uninfected BMDMs were used as normalized controls for infected 
BMDMs. All assays were performed in triplicates, and a non-template control was included in 
all experiments to exclude DNA contamination. Primers were obtained from Invitrogen and 
are listed in Tab. 1. 
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Gene Primer sequence 
Lc3b (for) 5’-TCATGGACTGAAGCCAGCATAG-3’ 
Lc3b (rev) 5’-TAGCAAAGACAGCTGCATGC-3’ 
Sqstm1/p62 (for) 5’-AAACATGGTGCACCCCAATG-3’ 
Sqstm1/p62 (rev) 5’-AGATGAGCTTGCTGTGTTCC-3’ 
Lamp1 (for) 5’-AGTCTTGTGTTGGCGTTCAG-3’ 
Lamp1 (rev) 5’-AGGCAATGCATTACGTGAGC-3’ 
Nqo1 (for) 5’-AGCGTTCGGTATTACGATCC-3’ 
Nqo1 (rev) 5’-AGTACAATCAGGGCTCTTCTCG-3’ 
Hmox-1 (for) 5’-GGTCAGGTGTCCAGAGAAGG-3’ 
Hmox-1 (rev) 5’-CTTCCAGGGCCGTGTAGATA-3’ 
Gclc (for) 5’-GTGGACGAGTGCAGCAAG-3’ 
Gclc (rev) 5’-GTCCAGGAAATACCCCTTCC-3’ 
Hprt (for) 5’-GTTGGATACAGGCCAGACTTTGTTG-3‘ 
Hprt (rev) 5’-GATTCAACTTGCGCTCATCTTAGGC-3‘ 
IL-1β (for) 5’-GTCCTGTGTAATGAAAGACGGC-3’ 
IL-1β (rev) 5’-CTGCTTGTGAGGTGCTGATGTA-3’ 
 
Table 1. List of primers used in this study. for, forward. rev, reverse. 
 
2.2.6 Statistical analyses 
Statistical analyses were performed using Prism software (GraphPad, version 5). 
Differences between groups were assessed by two-tailed unpaired Student´s t test or One-
way ANOVA with repeated measures when more than two groups were analyzed. Every 
single experiment was repeated at least three times. Unless otherwise specified, results are 
presented as mean ± standard deviation (SD). Differences were considered statistically 
significant when p ≤ 0.05 (∗), very significant when p ≤ 0.01 (∗∗), and highly significant when p 
≤ 0.001 (∗∗∗).  
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3. Results  
3.1 S. Typhimurium induces IFN-I signaling pathways in macrophages 
To investigate whether IFN-I signaling plays a role upon S. Typhimurium infection of 
macrophages, bone-marrow derived macrophages (BMDMs) from wild-type (WT) and IFN-I 
receptor deficient (Ifnar1-/-) mice were infected with S. Typhimurium and supernatants were 
subsequently analyzed by ELISA for IFN-β secretion. As shown in Fig. 1 A, S. Typhimurium 
infection induced the secretion of IFN-β, which is the major IFN-I secreted by murine 
macrophages, 6 hours (h) post infection (p.i.) in both WT and Ifnar1-/- BMDMs to a similar 
level. In S. Typhimurium-infected WT BMDMs, secreted IFN-β lead to the phosphorylation of 
the transcription factors STAT1 and STAT3, which are located downstream of the IFN-I 
receptor (Ifnar1). By contrast, phosphorylation of STAT1 and STAT3 was markedly reduced 
in infected Ifnar1-/- BMDMs as determined by immunoblot analysis (Fig. 1 B). These results 
demonstrate that S. Typhimurium infection induces the secretion of IFN-β that leads to auto- 
and paracrine engagement of Ifnar1 resulting in the activation of downstream IFN-I signaling 
pathways.    
 
 
 
 
 
 
Figure 1. S. Typhimurium infection induces IFN-I signaling pathways in macrophages.  
(A) Analysis of IFN-I secretion by ELISA. Supernatants of WT and Ifnar1-/- BMDMs were analyzed for IFN-β 
secretion, which is the predominant IFN-I in mice, 6 h after infection with S. Typhimurium (ST). UI, uninfected. 
(B) Immunoblot analysis of Ifnar1-dependent pathways. Phosphorylation of the transcription factors STAT1 and 
STAT3 was analyzed in total cell lysates of WT and Ifnar1-/- BMDMs at the indicated time points after infection 
with S. Typhimurium (ST). STAT1 and STAT3 function downstream of Ifnar1. p, phosphorylated. 
 
A 
p-STAT1 
p-STAT3 
β-actin 
B 
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3.2 S. Typhimurium induces IFN-I-mediated cell death of macrophages 
Previous work from our group has demonstrated that S. Typhimurium causes 
necroptotic cell death of macrophages, which was dependent on IFN-I signaling (Robinson 
et al. 2012).  To confirm this finding, WT and Ifnar1-/- BMDMs were infected with 
S. Typhimurium and cell death was assessed 6 h p.i. In line with our previous findings, 
S. Typhimurium infection caused significantly more cell death in WT BMDMs compared to 
Ifnar1-/- BMDMs (Fig. 2 A). Furthermore, we determined the amount of cellular ATP, which 
has commonly been used as a marker for cell viability, and found that S. Typhimurium 
infection reduced ATP levels of both WT and Ifnar1-/- BMDMs 2 h and 6 h p.i. (Fig. 2 B). When 
compared to infected Ifnar1-/- BMDMs, however, ATP levels were significantly lower in 
S. Typhimurium-infected WT BMDMs. These results therefore indicate that S. Typhimurium 
infection causes cell death and reduces energy levels of macrophages, which is further 
enhanced by IFN-I signaling. 
 
 
 
 
 
 
 
 
Figure 2. IFN-I signaling exacerbates S. Typhimurium-induced cell death of macrophages. 
(A) Luminescence analysis of IFN-I-dependent cell death. Luminescence signals of WT and Ifnar1-/- BMDMs were 
assessed to determine cell viability 6 h after S. Typhimurium infection. Values were normalized to the 
luminescence signal of uninfected WT BMDMs. 
(B) Luminescence analysis of relative ATP levels. WT and Ifnar1-/- BMDMs were infected with S. Typhimurium 
(ST) for the indicated time and the luminescence signals were measured to determine the amount of ATP. Values 
were normalized to ATP levels of uninfected (UI) WT BMDMs. Figure taken from (Hos et al. 2017). 
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3.3 IFN-I signaling exacerbates S. Typhimurium-induced mitochondrial damage 
Next, we sought to analyze the upstream events leading to S. Typhimurium-induced 
cell death of macrophages. As mitochondrial dysfunction has been identified as a major cause 
for cell death (Galluzzi et al. 2012), we first investigated whether mitochondrial damage 
precedes S. Typhimurium-induced cell death and whether mitochondrial dysfunction is 
dependent on IFN-I signaling.  
Using immunofluorescence microscopy, we assessed mitochondrial morphology in 
uninfected and S. Typhimurium-infected WT and Ifnar1-/- BMDMs stained with an antibody 
against the mitochondrial outer membrane protein Tom20. Uninfected WT and Ifnar1-/- 
BMDMs showed the typical tubular mitochondrial network, whereas WT and Ifnar1-/- BMDMs 
infected with S. Typhimurium for 6 h displayed increased mitochondrial fragmentation, 
indicative of mitochondrial damage (Fig. 3 A). Compared to Ifnar1-/- BMDMs, however, the 
integrity of the mitochondrial network appeared more disrupted in infected WT BMDMs. 
Consistently, electron microscopy revealed accumulation of damaged mitochondria in 
S. Typhimurium-infected WT BMDMs, whereas mitochondrial integrity was better conserved 
in Ifnar1-/- BMDMs 6 h p.i. (Fig. 3 B). 
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Figure 3. IFN-I signaling exacerbates S. Typhimurium-induced mitochondrial damage. 
(A) Immunofluorescence staining of mitochondrial network. WT and Ifnar1-/- BMDMs were infected with 
S. Typhimurium (ST) for 6 hours, immunostained for Tom20 (green) and examined by confocal microscopy (scale 
bars, 10 µm). Each inset represents a magnified image (scale bars, 4 µm). UI, uninfected. 
(B) Electron micrographs of mitochondria. Shown are three representative examples of mitochondria in uninfected 
(UI) or S. Typhimurium (ST)-infected WT and Ifnar1-/- BMDMs. Scale bar represents 250 nm.  
Figures taken from (Hos et al. 2017). 
 
Enhanced mitochondrial damage in WT BMDMs correlated with increased 
mitochondrial ROS (mtROS) production as determined by MitoSOX staining and decreased 
mitochondrial membrane potential (ψm) analyzed by TMRM fluorescence intensity. By 
contrast, S. Typhimurium-infected Ifnar1-/- BMDMs generated less mtROS consistent with 
sustained ψm (Fig. 4, A-C). Mitochondrial function was further assessed by analyzing the 
oxygen consumption rate (OCR) of S. Typhimurium-infected WT and Ifnar1-/- BMDMs using 
seahorse assay. As shown in Fig. 4 D, S. Typhimurium infection reduced the OCR in both 
WT and Ifnar1-/- BMDMs. However, the OCR was significantly lower in WT BMDMs compared 
to Ifnar1-/- BMDMs 6 h p.i.  
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Figure 4. IFN-I signaling impairs mitochondrial function in S. Typhimurium-infected macrophages. 
(A) Relative mitochondrial reactive oxygen species (mtROS) production. WT and Ifnar1-/- BMDMs were infected 
with S. Typhimurium (ST) for 6 h and the amounts of mtROS relative to uninfected (UI) WT BMDMs were analyzed 
by FACS using MitoSOX staining.  
(B) Flow cytometric analysis of mitochondrial membrane potential (ψm). WT and Ifnar1-/- BMDMs were infected 
with S. Typhimurium (ST) for 6 h and the number of TMRM positive cells was measured by flow cytometry. TMRM 
leaks from damaged mitochondria resulting in a loss of fluorescent intensity.  
(C) Quantification of mitochondrial membrane potential (ψm). ψm of uninfected (UI) and S. Typhimurium (ST)-
infected WT and Ifnar1-/- BMDMs was determined as described in (B) and changes of ψm from three independent 
experiments were subsequently quantified. 
(D) Measurement of relative oxygen consumption rate (OCR). Relative OCR was analyzed in WT and Ifnar1-/- 
BMDMs 6 h after S. Typhimurium (ST) infection by seahorse assay. The OCR was normalized to total cell numbers 
of WT and Ifnar1-/- BMDMs, respectively. UI, uninfected. 
Figures taken from (Hos et al. 2017). 
 
Furthermore, Tom20 expression, which has commonly been used as a marker for 
mitochondrial mass, was distinctly decreased in WT BMDMs 6 h after infection, whereas 
Tom20 levels remained unchanged in Ifnar1-/- BMDMs (Fig. 5, A and B). Taken together, 
these findings demonstrate that S. Typhimurium infection causes mitochondrial damage in 
macrophages. Importantly, IFN-I signaling further enhances mitochondrial dysfunction upon 
S. Typhimurium infection of macrophages.  
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Figure 5. IFN-I signaling decreases mitochondrial mass of S. Typhimurium-infected macrophages. 
(A) Immunoblot analysis of mitochondrial mass. WT and Ifnar1-/- BMDMs were infected with S. Typhimurium (ST) 
for the indicated time and total cell lysates were immunostained for Tom20 as a marker for mitochondrial mass.  
(B) Relative Tom20 expression was determined by densitometric quantification from three independent 
immunoblots. UI, uninfected; ST, S. Typhimurium. 
Figures taken from (Hos et al. 2017). 
 
3.4 IFN-I-mediated mitochondrial damage and energy depletion transiently triggers 
autophagy  
As mitochondria are the main sources of cellular ATP, damage of mitochondria 
interferes with cellular energy homeostasis and eventually results in energy depletion. Many 
studies have convincingly shown that reduced energy levels lead to the activation of 
autophagy, which enables the cell to restore energy homeostasis by recycling cellular 
organelles and protein aggregates through lysosomal degradation (Deretic et al. 2013; 
Mizushima et al. 2008).  
Having shown that S. Typhimurium infection causes mitochondrial damage and 
energy depletion in macrophages, we next investigated whether reduced ATP levels trigger 
autophagy. Indeed, electron microscopy revealed that 2 h after S. Typhimurium infection 
autophagosomes were formed in both WT and Ifnar1-/- BMDMs (Fig. 6 A). To assess 
autophagic activity more precisely, we determined the expression levels of the autophagic 
adaptor protein p62 and the autophagic marker proteins LC3-I and LC3-II following 
S. Typhimurium infection of macrophages. P62 and autophagosome-associated LC3-II 
A B 
34 
 
(lipidated form) are degraded along with the autolysosome and their amounts are therefore 
inversely correlated with autophagic flux. As shown in Fig. 6 B, S. Typhimurium infection 
induced the expression of p62 and LC3 in WT and Ifnar1-/- BMDMs at 2 h, 4 h and 6 h p.i. as 
determined by immunoblot. Of note, S. Typhimurium infection transiently induced LC3-I to 
LC3-II conversion in WT BMDMs (2 h p.i.), indicative of autophagy induction, while LC3-I to 
LC3-II conversion rates were markedly attenuated after 4 h and 6 h of infection, respectively, 
indicative of blocked autophagic flux. By contrast, autophagic flux was constantly reduced in 
S. Typhimurium-infected Ifnar1-/- BMDMs, as shown by a low LC3 I to II conversion rate and 
a strong accumulation of p62 (4 h and 6 h p.i.; Fig. 6, C and D).  
 
Figure 6. Mitochondrial damage results in the transient induction of autophagy. 
(A) Electron micrographs of autophagosome formation in S. Typhimurium-infected WT and Ifnar1-/- BMDMs (2 h 
p.i.). Arrows point to double-membrane structures indicative of autophagosome formation. Scale bar, 500 nm. 
(B) Immunoblot analysis of autophagy marker proteins. WT and Ifnar1-/- BMDMs were infected with 
S. Typhimurium (ST) for the indicated time or treated with Torin1 (10 µM, 4 h), and p62 and LC3 expression were 
determined in total cell lysates by immunoblot. Torin1 inhibits mTORC1 and was used as a positive control for 
autophagy induction.  
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(C and D) LC3 I to LC3 II conversion rates (C) and relative p62 expression levels (D) were determined from three 
independent immunoblots by densitometric quantification. UI, uninfected. ST, S. Typhimurium. 
Figures taken from (Hos et al. 2017). 
 
We further confirmed that IFN-I positively regulates autophagy by using a 
neutralization antibody against murine IFN-β. As shown in Fig. 7 A, neutralizing IFN-β during 
S. Typhimurium infection markedly enhanced the accumulation of p62 indicative of reduced 
autophagy. In fact, p62 levels of WT BMDMs treated with an antibody against IFN-β were 
similar to the amount of p62 of autophagy-deficient Atg7-/- BMDMs. Consistent with our 
observation that Ifnar1-/- BMDMs showed reduced autophagic activity, mRNA expression 
levels of Lc3b (LC3) and Lamp1, a central regulator of lysosomal biogenesis, were also 
significantly decreased (Fig. 7, B and C).  
 
 
 
 
 
 
 
Figure 7. IFN-I signaling transiently induces autophagy in S. Typhimurium-infected macrophages. 
(A) Immunoblot analysis of p62 expression upon blockade of IFN-I signaling. P62 expression was determined in 
S. Typhimurium (ST)-infected WT BMDMs upon neutralization of IFN-β at the indicated time points in comparison 
to infected WT and Atg7-/- BMDMs treated with an IgG control. α-IFN-β, anti-IFN-β neutralizing antibody. 
(B and C) Relative Lc3b and Lamp1 mRNA expression. WT and Ifnar1-/- BMDMs were infected with 
S. Typhimurium (ST) for the indicated time and relative (B) Lc3b and (C) Lamp1 mRNA expression was 
determined by real-time PCR. Values were normalized to the amounts of mRNA of uninfected (UI) BMDMs.  
Figures taken from (Hos et al. 2017). 
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Importantly, Ifnar1-/- BMDMs were not generally deficient in autophagy, since LC3 I 
to II conversion was observed upon Torin1 treatment, which pharmacologically inhibits 
mTORC1 activation thereby inducing autophagy (Fig. 6 B). Differential autophagy levels in 
WT and Ifnar1-/- BMDMs, however, were not due to altered mTORC1 signaling, as 
phosphorylation levels of p70 S6 kinase, a downstream target of mTORC1, did not differ 
significantly (Fig. 8 A). Furthermore, transient activation of autophagy did not have a 
significant effect on the ability of WT BMDMs to clear S. Typhimurium compared to infected 
Ifnar1-/- BMDMs (Fig. 8 B).  
 
 
Figure 8. S. Typhimurium manipulates autophagy independent of mTORC1. 
(A) Immunoblot analysis of mTORC1 activation. Total cell lysates of WT and Ifnar1-/- BMDMs infected with 
S. Typhimurium for the indicated time were analyzed for expression and phosphorylation of p70 S6 kinase (S6K) 
by immunoblot. Phosphorylation of p70 S6K is mediated by mTORC1 and can be inhibited by Torin1 (10 µM, 4 h), 
which is a pharmacological mTORC1 inhibitor. 
(B) Determination of bacterial burden. The number of live bacteria was determined by counting colony forming 
units (cfu) on agar plates incubated with lysates of WT and Ifnar1-/- BMDMs 24 h after infection with 
S. Typhimurium. 
Figures taken from (Hos et al. 2017). 
 
Collectively, S. Typhimurium infection transiently induces autophagy in macrophages 
(2 h p.i.), while autophagy is inhibited during the later course of infection (4 h and 6 h p.i.). 
Importantly, the early induction of autophagy is mediated by IFN-I signaling, while the 
blockade of autophagy occurs independent of IFN-I signaling. As a result, blockade of 
autophagy leads to the accumulation of p62 in S. Typhimurium-infected macrophages. 
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3.5 Reduced p62 levels contribute to IFN-I-mediated cell death  
As our previous experiments have shown that p62 levels are markedly elevated in 
S. Typhimurium-infected macrophages, we further investigated the functional consequence 
of p62 accumulation. Recent studies on autophagy-deficient cells have demonstrated that 
p62 mediates the formation of cytosolic inclusion bodies in response to oxidative stress 
(Komatsu et al. 2007). Furthermore, p62-positive protein aggregates have been observed 
during neurodegenerative and chronic liver diseases and have been considered as a 
pathognomic feature of these diseases (Umemura et al. 2016; Zatloukal et al. 2002).  
To investigate whether p62-positive protein aggregates also occur in S. Typhimurium-
infected macrophages, confocal microscopy on WT and Ifnar1-/- BMDMs infected with 
S. Typhimurium for 6 h and stained with an antibody against p62 was performed. Consistent 
with our immunoblot analyses, p62 expression was also enhanced in S. Typhimurium-
infected WT BMDMs and p62 levels were even further enhanced in infected Ifnar1-/- BMDMs 
(Fig. 9, A and B). Importantly, elevated p62 levels of Ifnar1-/- BMDMs were not due to 
increased Sqstm1 (the gene encoding p62) mRNA transcription, although a moderate 
upregulation of Sqstm1 mRNA was observed in S. Typhimurium-infected Ifnar1-/- BMDMs 
compared to WT controls (Fig. 9 C).  
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Figure 9. IFN-I signaling decreases p62 levels of S. Typhimurium-infected macrophages. 
(A) Immunofluorescence staining of p62. After infection with S. Typhimurium (ST) for 6 h, WT and Ifnar1-/- BMDMs 
were immunostained for p62 (green) and examined by confocal microscopy (scale bars, 10 µm). UI, uninfected. 
(B) Quantification of p62 puncta. The number of p62 positive puncta per cell was quantified in WT and Ifnar1-/- 
BMDMs 6 h after infection with S. Typhimurium (ST) (n=50 cells each, repeated for three times). UI, uninfected. 
(C) Relative Sqstm1 (p62) mRNA expression. WT and Ifnar1-/- BMDMs were infected with S. Typhimurium (ST) 
for the indicated time and Sqstm1 (the gene encoding p62) mRNA expression was determined by real-time PCR. 
Values were normalized to the amounts of mRNA in uninfected (UI) BMDMs.  
Figures taken from (Hos et al. 2017). 
 
As depicted in Fig. 9 A, p62 assembled on large protein aggregates (≥1µm) in the 
perinuclear region of both WT and Ifnar1-/- BMDMs 6 h after S. Typhimurium infection. 
Because of this localization pattern, we reasoned that enhanced p62 levels upon 
S. Typhimurium infection were caused by impaired autophagic degradation of p62. 
Consistently, pharmacological treatment of infected WT and Ifnar1-/- BMDMs with the 
lysosomal inhibitor Concanamycin A for 4 h and 6 h further elevated p62 levels compared to 
untreated controls (Fig. 10, A and B). Therefore, elevated p62 levels in S. Typhimurium-
infected macrophages were due to decreased autophagic degradation. 
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Figure 10. P62 is degraded through the autophagic pathway. 
(A) Immunoblot analysis of p62 expression upon blockade of autophagy. WT and Ifnar1-/- BMDMs were either 
infected with S. Typhimurium (ST) or pretreated with Concanamycin A (ConcA; 100 nM, 2 h) and then infected 
with S. Typhimurium in the presence of 50 nM Concanamycin A for the indicated time. Total cell lysates were 
subjected to immunoblot and were stained with an antibody against p62. Concanamycin A inhibits lysosomal 
acidification of the autophagosome and is used to determine autophagic turnover. 
(B) Relative p62 expression levels were determined from three independent immunoblots by densitometric 
quantification. UI, uninfected. ST, S. Typhimurium.  
Figures taken from (Hos et al. 2017). 
 
Having shown that p62 markedly accumulates in Ifnar1-/- BMDMs, we next analyzed 
whether elevated p62 levels promote increased survival of S. Typhimurium-infected Ifnar1-/- 
BMDMs. For this purpose, WT and Ifnar1-/- BMDMs were transfected with control or 
Sqstm1/p62-specific small-interfering RNA (siRNA) and knockdown of p62 was subsequently 
confirmed by immunoblot (Fig. 11 A).  Next, p62-dependent macrophage viability was 
determined 6 h after S. Typhimurium infection using a luminescent assay. As expected, 
survival rates of Ifnar1-/- BMDMs transfected with control siRNA, which expressed higher 
levels of p62, showed significantly increased survival compared to the corresponding WT 
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BMDMs (Fig. 11 B). Importantly, knockdown of p62 significantly reduced cell viability in both 
WT and Ifnar1-/- BMDMs (Fig. 11 B) indicating that p62 plays a crucial role in the cell-
autonomous defense against S. Typhimurium.   
 
 
 
 
 
Figure 11. P62 promotes survival of S. Typhimurium-infected macrophages. 
(A) Immunoblot analysis of p62 knockdown efficiency. WT and Ifnar1-/- BMDMs were transfected with non-
targeting (siCtrl) or siRNA specific for Sqstm1/p62 (sip62). Thereafter, total cell lysates were analyzed for p62 
expression by immunoblot. 
(B) Luminescence analysis of p62-dependent cell death. Luminescence signals of WT and Ifnar1-/- BMDMs 
transfected with non-targeting (siCtrl) or Sqstm1/p62-specific (sip62) siRNA were assessed to determine cell 
viability 6 h after S. Typhimurium infection. Values were normalized to luminescence signal of uninfected WT siCtrl 
BMDMs. 
Figures taken from (Hos et al. 2017). 
 
Since some studies have suggested that autophagy is a critical host defense 
mechanism against S. Typhimurium (Thurston et al. 2009; Zheng et al. 2009), we additionally 
analyzed cell viability of autophagy-deficient Atg7-/- BMDMs upon infection with 
S. Typhimurium. As shown in Fig. 12, Atg7-/- BMDMs infected with S. Typhimurium for 6 h 
survived even less than WT BMDMs. However, neutralization of IFN-β protected both WT 
and Atg7-/- BMDMs from S. Typhimurium-induced cell death (Fig. 12). We therefore conclude 
that IFN-I signaling mediates cell death upon S. Typhimurium infection independent of 
autophagy, but dependent on p62.  
 
 
A B 
41 
 
 
 
 
 
 
 
 
 
 
Figure 12. IFN-I signaling mediates cell death of S. Typhimurium-infected macrophages independent of 
autophagy. 
Luminescence analysis of autophagy- and IFN-dependent cell death. Autophagy-dependent cell death was 
determined by measuring the luminescence signals of WT and autophagy-deficient Atg7-/- BMDMS 6 h after 
S. Typhimurium infection. Additionally, IFN-I-dependent cell death was assessed in WT and Atg7-/- BMDMS in the 
presence of a neutralizing antibody against IFN-β. Values were normalized to luminescence signals of uninfected 
WT BMDMs treated with an IgG control antibody. 
Figure taken from (Hos et al. 2017). 
 
3.6 IFN-I signaling attenuates Nrf2 activation and anti-oxidative responses  
Previous work by Komatsu and co-workers as well as by Lau and co-workers has 
indicated that p62 is of major relevance for regulating anti-oxidative stress response pathways 
in hepatocytes and epithelial kidney cells, respectively. These authors suggested that high 
levels of p62 protect cells from pharmacologically induced oxidative damage and cell death.  
(Komatsu et al. 2010; Lau et al. 2010). Mechanistically, p62 interacts with the Nrf2 binding 
site on Keap1. As a result of p62-Keap1 interaction, the transcription factor Nrf2 is released 
from Keap1, stabilized and translocated to the nucleus, where it induces the expression of 
various detoxifying enzymes and cytoprotective proteins (Ichimura et al. 2013; Komatsu et al. 
2010; Lau et al. 2010).  
Since p62 strongly accumulated in S. Typhimurium-infected Ifnar1-/- BMDMs, we next 
analyzed whether p62 accumulation correlated with increased Nrf2 activation. As shown in 
Fig. 13 A and B, Nrf2 protein expression of Ifnar1-/- BMDMs was significantly enhanced after 
2 h, 4 h and 6 h of S. Typhimurium infection compared to WT BMDMs, whereas Keap1 
expression was decreased 6 h p.i. (Fig. 13 C). Importantly, IFN-I signaling reduced Nrf2 post-
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transcriptionally, because mRNA expression was significantly decreased in S. Typhimurium-
infected Ifnar1-/- BMDMs (Fig. 13 D). 
 
 
 
 
 
 
 
 
 
Figure 13. IFN-I signaling decreases Nrf2 protein expression in S. Typhimurium-infected macrophages. 
(A) Immunoblot analysis of Nrf2 and Keap1. After S. Typhimurium (ST) infection for the indicated time points, total 
cell lysates of WT and Ifnar1-/- BMDMs were analyzed for Nrf2 and Keap1 expression by immunoblot.  
(B and C) Relative expression of (B) Nrf2 and (C) Keap1 was determined from three independent immunoblots 
by densitometric quantification. UI, uninfected. ST, S. Typhimurium.  
Figures taken from (Hos et al. 2017). 
(D) Relative mRNA expression of Nrf2. Relative mRNA expression of Nrf2 in S. Typhimurium (ST)-infected WT 
and Ifnar1-/- BMDMs was determined by real-time PCR. Values were normalized to the amounts of mRNA in 
uninfected (UI) BMDMs.  
 
Using confocal microscopy, we next analyzed p62-Keap1 interaction in infected WT 
and Ifnar1-/- BMDMs stained with antibodies against p62 and Keap1. As shown in Fig. 14 A 
and B, p62 strongly co-localized with Keap1 in infected Ifnar1-/- BMDMs. Consistently, we 
detected significantly more Nrf2 in the nucleus of Ifnar1-/- BMDMs compared to WT BMDMs 
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6 h p.i. (Fig. 14, C-E). Furthermore, relative mRNA expression levels of Nrf2 target genes, 
including Nqo1, Hmox-1 and Gclc, were significantly upregulated in Ifnar1-/- BMDMs 2 h and 
6 h p.i., respectively, compared to the expression levels in WT BMDMs (Fig. 14, F-H).  
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Figure 14. IFN-I signaling attenuates Nrf2 activation and anti-oxidative stress responses in 
S. Typhimurium-infected macrophages. 
(A) Immunofluorescence staining of subcellular distribution of p62 and Keap1. WT and Ifnar1-/- BMDMs were 
infected with S. Typhimurium (ST) for the indicated time and were immunostained for p62 (green) and Keap1 
(red), and were examined by confocal microscopy. Scale bars, 10 µm. UI, uninfected. 
(B) p62-Keap1 co-localization. Pearson correlation coefficient was used to assess p62 and Keap1 co-localization 
in WT and Ifnar1-/- BMDMs 6 h after infection with S. Typhimurium. 
(C) Immunofluorescence staining of nuclear Nrf2. After 6 h of S. Typhimurium (ST) infection, WT and Ifnar1-/- 
BMDMs were immunostained for Nrf2 (green) and examined by confocal microscopy. Scale bars, 10 µm. UI, 
uninfected. 
(D) Quantification of nuclear Nrf2. Mean fluorescent intensity (MFI) of nuclear Nrf2 was measured using 
densitometric quantification (n=50 cells each, repeated for three times). UI, uninfected. 
(E) Immunoblot analysis of nuclear Nrf2. Nuclear fractions of WT and Ifnar1-/- BMDMs were prepared 6 h after 
S. Typhimurium infection and were subjected to immunoblot analysis for Nrf2 expression. Lamin B (nuclear 
fraction) and GAPDH (cytoplasmic fraction) were used as controls.  
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(F-H) Relative mRNA expression of Nrf2-dependent genes. Relative mRNA expression levels of (F) Nqo1, (G) 
Hmox-1 and (H) Gclc in S. Typhimurium (ST)-infected WT and Ifnar1-/- BMDMs were determined by real-time 
PCR. Values were normalized to the amounts of mRNA in uninfected (UI) BMDMs.  
Figures taken from (Hos et al. 2017). 
 
To confirm that the upregulation of cytoprotective genes in Ifnar1-/- BMDMs was 
mediated by p62, we transfected Ifnar1-/- BMDMs with control or anti-Sqstm1/p62 siRNA (Fig. 
15 A) and determined relative mRNA expression levels of Nqo1, Hmox-1 and Gclc upon 
infection with S. Typhimurium. As shown in Fig. 15, B to D, genetic silencing of Sqstm1/p62 
significantly reduced Nqo1, Hmox-1 and Gclc expression 6 h p.i. To confirm that p62 
accumulation and not autophagy deficiency promotes anti-oxidative responses to 
S. Typhimurium, the expression levels of Nrf2-dependent target genes were additionally 
assessed in autophagy-deficient Atg7-/- BMDMs. Autophagy deficiency had no significant 
effect on Nrf2-dependent gene expression, since expression levels of Nqo1 and Gclc were 
similar in infected WT and Atg7-/- BMDMs (Fig. 15, E and F). Neutralization of IFN-β, however, 
significantly increased mRNA expression of Nqo1 and Gclc in both WT and Atg7-/- BMDMs 
(Fig. 15, E and F), indicating that p62 expression but not autophagy deficiency is critical for 
anti-oxidative stress responses to S. Typhimurium.  
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Figure 15. P62 mediates anti-oxidative stress responses to S. Typhimurium. 
(A) Immunoblot analysis of p62 knockdown efficiency. Ifnar1-/- BMDMs were transfected with non-targeting (siCtrl) 
or siRNA specific for Sqstm1/p62 (sip62). Thereafter, total cell lysates were analyzed by immunoblot for p62 
expression.   
(B-D) P62-dependent mRNA expression of Nrf2 downstream genes. Relative mRNA expression levels of (B) 
Nqo1, (C) Hmox-1 and (D) Gclc in S. Typhimurium (ST)-infected Ifnar1-/- BMDMs transfected with non-targeting 
(siCtrl) or siRNA specific for Sqstm1/p62 (sip62) were determined by real-time PCR. Values were normalized to 
the amounts of mRNA in uninfected (UI) siCtrl BMDMs.  
(E and F) Autophagy- and IFN-I-dependent expression of Nrf2 downstream genes. WT and Atg7-/- BMDMs 
infected with S. Typhimurium (ST) in the presence or absence of a neutralization antibody against IFN-β were 
assessed for the relative mRNA expression of (E) Nqo1 and (F) Gclc. Values were normalized to the amounts of 
mRNA in uninfected (UI) WT BMDMs treated with an IgG control antibody. 
Figures taken from (Hos et al. 2017). 
 
Taken together, these results demonstrate that S. Typhimurium-induced IFN-I 
signaling interferes with p62-Keap1 interaction. IFN-I signaling reduces p62 levels in 
S. Typhimurium-infected macrophages, which results in decreased p62-Keap1 interaction 
eventually leading to impaired Nrf2-dependent cytoprotective gene expression. 
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3.7 Impaired Nrf2 function mediates S. Typhimurium-induced cell death 
Having shown that IFN-I signaling reduces Nrf2 activation and the ability to respond 
to S. Typhimurium-induced oxidative stress, we next analyzed whether impaired Nrf2 
activation sensitizes macrophages to cell death.  
For this purpose, WT and Ifnar1-/- BMDMs were transfected with control or Nfe2I2 (the 
gene encoding Nrf2)-specific siRNA and cell death upon S. Typhimurium infection was 
assessed using a luminescence assay. Knockdown of Nrf2 was confirmed by immunoblot 
analysis (Fig. 16 A). In line with our previous findings, S. Typhimurium infection caused 
significantly more cell death in WT BMDMs compared to Ifnar1-/- BMDMs transfected with 
control siRNA (Fig. 16 B). In WT BMDMs, in which Nrf2 function is already impaired by IFN-
I, genetic silencing of Nrf2 had no additional effect on S. Typhimurium-induced cell death. By 
contrast, Nrf2-deficient Ifnar1-/- BMDMs were more susceptible to cell death than Ifnar1-/- 
transfected with control siRNA. In fact, cell death caused by S. Typhimurium infection in Nrf2-
deficient Ifnar1-/- BMDMs was comparable to the amount of cell death in Nrf2-deficient WT 
BMDMs (Fig. 16 B). Hence, Nrf2 critically mediates increased survival of Ifnar1-/- BMDMs 
upon S. Typhimurium infection. 
To confirm the predominant role of Nrf2 in regulating cell viability, we 
pharmacologically modified Nrf2 function in WT and Ifnar1-/- BMDMs during infection with 
S. Typhimurium. Cell viability was subsequently analyzed 6 h p.i. using a luminescent assay. 
In line with our Nrf2 knockdown data, pharmacological inhibition of Nrf2 using Trigonelline 
significantly reduced cell viability in infected Ifnar1-/- BMDMs compared to untreated controls, 
whereas there was only a modest reduction of cell viability in infected WT BMDMs (Fig. 16 C). 
By contrast, pharmacological activation of Nrf2 by CDDO markedly enhanced WT viability 
following S. Typhimurium infection, whereas CDDO had no statistically significant effect on 
survival of infected Ifnar1-/- BMDMs (Fig. 16 C), in which Nrf2 function is already highly 
upregulated. 
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Figure 16. IFN-I signaling induces cell death through impairing Nrf2. 
(A) Immunoblot analysis of Nrf2 knockdown efficiency. WT and Ifnar1-/- BMDMs were transfected with non-
targeting (siCtrl) or siRNA specific for Nfe2I2 (siNrf2). Thereafter, total cell lysates were analyzed by Western blot 
for Nrf2.  
(B) Luminescence analysis of Nrf2-dependent cell death. Luminescence signals of WT and Ifnar1-/- BMDMs 
transfected with non-targeting (siCtrl) or siRNA specific for Nfe2I2 (siNrf2) were assessed to determine cell viability 
upon infection with S. Typhimurium (6 h p.i.). Values were normalized to luminescence signal of uninfected WT 
BMDMs.  
(C) Luminescence analysis of cell death upon pharmacological modulation of Nrf2 activation. Luminescence 
signals of WT and Ifnar1-/- BMDMs treated with the Nrf2 activator CDDO (500 nM, 6 h) or with the Nrf2 inhibitor 
Trigonelline (100 µM, 6 h) were determined to analyze cell viability 6 h after S. Typhimurium infection. Values were 
normalized to luminescence signal of uninfected, untreated WT BMDMs.  
Figures taken from (Hos et al. 2017). 
 
Having demonstrated that S. Typhimurium infection induces mtROS in macrophages 
(Fig. 4 A), we next assessed whether mtROS production was dependent on Nrf2 activation. 
For this purpose, WT and Ifnar1-/- BMDMs were infected with S. Typhimurium for 6 h and 
mitochondrial ROS was quantified using MitoSOX staining upon knockdown of Nrf2. As 
shown in Fig. 17 A, knockdown of Nrf2 significantly enhanced mitochondrial ROS production 
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in WT and Ifnar1-/- BMDMs compared to controls. As we observed that WT BMDMs were 
more susceptible to S. Typhimurium-induced cell death because of impaired Nrf2 function 
and reduced anti-oxidative stress responses, we surmised that scavenging mitochondrial 
ROS might be cytoprotective. Therefore, we specifically quenched mitochondrial ROS in 
S. Typhimurium-infected WT BMDMs using mitoTEMPO. In fact, quenching mitochondrial 
ROS significantly improved WT survival compared to untreated controls (Fig. 17 B), indicating 
that disturbed redox homeostasis caused by S. Typhimurium infection is an important trigger 
for cell death.  
 
 
 
 
 
 
Figure 17. Impaired Nrf2 function causes cell death through mitochondrial ROS. 
(A) Nrf2-dependent mitochondrial reactive oxygen species (mtROS) production. WT and Ifnar1-/- BMDMs were 
transfected with non-targeting (siCtrl) or siRNA specific for Nfe2I2 (siNrf2). Transfected BMDMs were infected with 
S. Typhimurium for 6 h and the amounts of mtROS relative to uninfected WT siCtrl BMDMs were analyzed by 
FACS using MitoSOX staining.  
(B) Luminescence analysis of ROS-dependent cell death. Luminescence signals of WT BMDMs treated with or 
without the mtROS scavenger mitoTEMPO (100 µM, 6 h) were analyzed to determine cell viability upon 
S. Typhimurium (ST) infection (6 h p.i.). Values were normalized to luminescence signal of uninfected, untreated 
WT BMDMs.  
Figures taken from (Hos et al. 2017). 
 
Collectively, these results demonstrate that S. Typhimurium-induced IFN-I impairs 
Nrf2 activation, which leads to increased mitochondrial ROS production eventually sensitizing 
infected macrophages to cell death.   
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3.8 Nrf2 function is regulated by RIP3  
We have recently shown that S. Typhimurium exploits the host`s IFN-I response to 
induce RIP1- and RIP3-mediated necroptosis in macrophages (Robinson et al. 2012). As RIP 
kinases act downstream of the IFN-I receptor, we speculated that IFN-I regulates Nrf2 
function through RIP signaling.  
As shown in Fig. 18 A, S. Typhimurium infection lead to the activation of necroptosis 
pathways indicated by phosphorylation of RIP3 2 h and 6 h p.i., which was mediated by IFN-
I signaling. Accordingly, S. Typhimurium infection promoted the phosphorylation of MLKL 
(Fig. 18 A), a downstream target of RIP3, which was remarkably reduced in infected Ifnar1-/- 
(Fig. 18 A) and RIP3-/- BMDMs (Fig. 18 B). As S. Typhimurium infection induced more IL-1β 
expression in Ifnar1-/- BMDMs compared to WT BMDMs, we excluded pyroptosis as the 
predominant type of cell death mediated by IFN-I signaling (Fig. 18, C and D). Similar to 
Ifnar1-/- BMDMs, S. Typhimurium-infected RIP3-/- BMDMs showed accumulation of p62, 
reduced Keap1 and increased Nrf2 expression compared to infected WT BMDMs (Fig. 18 E). 
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Figure 18. S. Typhimurium infection activates RIP3 downstream of Ifnar1. 
(A and B) Immunoblot analysis of RIP3 and MLKL activation. After S. Typhimurium (ST) infection for the indicated 
time, total cell lysates of (A) WT and Ifnar1-/- or (B) WT and RIP3-/- BMDMs, respectively, were subjected to 
immunoblot analysis and were stained with antibodies against RIP3, phsopho-RIP3 (p-RIP3), MLKL and phospho-
MLKL (p-MLKL) as markers for necroptotic pathway activation. 
(C) Relative IL-1β mRNA expression. WT and Ifnar1-/- BMDMs were infected with S. Typhimurium (ST) for 6 h and 
relative IL-1β mRNA expression was determined by real-time PCR. Values were normalized to the amounts of 
mRNA of uninfected (UI) BMDMs.  
(D) Analysis of IL-1β secretion. Supernatants of WT and Ifnar1-/- BMDMs infected with S. Typhimurium (ST) for 
6 h and 24 h, respectively, were collected and analyzed for IL-1 β secretion by ELISA. 
(E) Immunoblot analysis of p62, Keap1 and Nrf2. Expression levels of p62, Keap1 and Nrf2 were analyzed by 
immunoblot in total cell lysates of S. Typhimurium (ST)-infected WT and RIP3-/- BMDMs at the indicated time 
points. 
Figures taken from (Hos et al. 2017). 
 
We additionally assessed nuclear translocation of Nrf2 by confocal microscopy and 
found that loss of RIP3 facilitated nuclear translocation of Nrf2 6 h after S. Typhimurium 
infection (Fig. 19 A). Additionally, we detected more Nrf2 in the nuclear fractions of infected 
RIP3-/- BMDMs compared to WT BMDMs (Fig. 19 B). Enhanced nuclear localization of Nrf2 
in RIP3-/- BMDMs resulted in significantly upregulated Nqo1 and Gclc mRNA expression 6 h 
p.i. (Fig. 19, C and D).  
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Figure 19. RIP3 impairs Nrf2 function in S. Typhimurium-infected macrophages. 
(A) Immunofluorescence staining of nuclear Nrf2. After 6 h of S. Typhimurium (ST) infection, WT and RIP3-/- 
BMDMs were immunostained for Nrf2 (green) and subcellular localization of Nrf2 was examined by confocal 
microscopy. Scale bars, 10 µm. UI, uninfected. 
(B) Immunoblot analysis of nuclear Nrf2. Nuclear fractions of WT and RIP3-/- BMDMs were prepared 6 h after 
S. Typhimurium infection and were subjected to immunoblot analysis for Nrf2 expression. Lamin B (nuclear 
fraction) and GAPDH (cytoplasmic fraction) were used as controls.  
(C and D) RIP3-dependent expression of Nrf2 target genes. Relative mRNA expression levels of (C) Nqo1 and 
(D) Gclc in S. Typhimurium (ST)-infected WT and RIP3-/- BMDMs were determined by real-time PCR. Values were 
normalized to the amounts of mRNA of uninfected (UI) BMDMs. 
Figures taken from (Hos et al. 2017). 
 
These results collectively indicate that IFN-I signaling activates RIP3, which interferes 
with Nrf2 function resulting in an impaired anti-oxidative response to S. Typhimurium 
infection. 
 
3.9 Pgam5 prevents Nrf2 activation downstream of IFN-I/RIP3  
We next sought to identify the mechanism by which IFN-I/RIP3 signaling impairs Nrf2 
function. Wang and co-workers have reported previously that MLKL mediates the interaction 
of RIP1- and RIP3-containing protein complexes with the mitochondrial phosphatase Pgam5 
upon TNF-induced necrosis (Wang et al. 2012). Pgam5 is subsequently recruited to the outer 
mitochondrial membrane, where it forms a ternary complex with Nrf2 and Keap1, in which 
Keap1 bridges Pgam5 and Nrf2 (Lo and Hannink 2008). We therefore investigated whether 
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IFN-I/RIP3 signaling regulates Pgam5 expression upon S. Typhimurium infection of 
macrophages and whether Pgam5 affects Nrf2 activation.  
As shown in Fig. 20 A and B, S. Typhimurium infection induced the expression of 
Pgam5 in WT, Ifnar1-/- and RIP3-/- BMDMs 2 h and 6 h p.i., respectively. However, loss of 
either IFN-I or RIP3 markedly reduced Pgam5 expression (Fig. 20, A and B). To investigate 
whether Pgam5 interacts with Nrf2, anti-Nrf2 immunoprecipitates of WT, Ifnar1-/- and RIP3-/- 
BMDMs were analyzed by immunoblot. Pgam5 strongly co-immunoprecipated with Nrf2 in 
WT BMDMs 6 h after S. Typhimurium infection, whereas Pgam5 was not detectable in anti-
Nrf2 immunoprecipitates of Ifnar1-/- and RIP3-/- BMDMs (Fig. 20, C and D). This finding 
therefore indicates that S. Typhimurium-induced IFN-I/RIP3 signaling promotes the formation 
of a protein complex comprising Pgam5 and Nrf2.  
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Figure 20. IFN-I/RIP3 signaling promotes the interaction of Pgam5 with Nrf2.  
(A and B) Immunoblot analysis of Pgam5. At the indicated time points, total cell lysates of S. Typhimurium (ST)-
infected (A) WT and Ifnar1-/- BMDMs or (B) WT and RIP3-/- BMDMs were subjected to immunoblot and were 
analyzed for Pgam5 expression.  
(C and D) Immunoprecipitation analyses. Anti-Nrf2 immunoprecipitates (IP) and whole cell lysates from (C) WT 
and Ifnar1-/- BMDMs or (D) WT and RIP3-/- BMDMs infected with S. Typhimurium (ST) for 6 h were analyzed by 
immunoblot (IB) with antibodies against Pgam5 and Nrf2. Samples treated with non-specific IgG were used as 
controls.  
Figures taken from (Hos et al. 2017). 
 
As Pgam5 interacts with Nrf2, we next sought to investigate whether Pgam5 regulates 
Nrf2 function. For this purpose, WT BMDMs were transfected with either control or Pgam5-
specific siRNA and knockdown of Pgam5 was confirmed by immunoblot (Fig. 21 A). Using 
confocal microscopy, we found that genetic silencing of Pgam5 enhanced nuclear 
translocation of Nrf2 6 h after infection with S. Typhimurium compared to WT controls (Fig. 
21 B), which resulted in the enhanced transcription of Nrf2-dependent Nqo1 (Fig. 21 C).  
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Figure 21. Pgam5 prevents Nrf2 activation downstream of IFN-I/RIP3. 
(A) Immunoblot analysis of Pgam5 knockdown efficiency. WT BMDMs were transfected with non-targeting (siCtrl) 
or Pgam5-specific siRNA (siPgam5). Thereafter, Pgam5 knockdown efficiency was determined in total cell lysates 
by immunoblotting.  
(B) Immunofluorescence staining of nuclear Nrf2. WT BMDMs were transfected with non-targeting (siCtrl) or 
Pgam5-specific siRNA (siPgam5). After 6 h of S. Typhimurium (ST) infection, transfected BMDMs were 
immunostained for Nrf2 (green) and subcellular localization of Nrf2 was examined by confocal microscopy. Scale 
bars, 10 µm. UI, uninfected.  
(C) Pgam5-dependent Nqo1 mRNA expression. WT BMDMs were transfected with non-targeting (siCtrl) or 
Pgam5-specific siRNA (siPgam5) and infected with S. Typhimurium (ST) for 6 h. Relative mRNA expression of 
Nqo1 was subsequently determined by real-time PCR. Values were normalized to the amounts of mRNA in 
uninfected (UI) WT siCtrl BMDMs.  
Figures taken from (Hos et al. 2017). 
 
In summary, these results indicate that S. Typhimurium infection enhances the 
interaction of Pgam5 with Nrf2 through activation of IFN-I and RIP3 signaling pathways. 
Enhanced Pgam5-Nrf2 interaction eventually impairs Nrf2 function and Nrf2-dependent redox 
homeostasis of S. Typhimurium-infected macrophages. 
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4. DISCUSSION 
An important virulence strategy of S. Typhimurium is the induction of cell death within 
cells of the innate immune system. This enables S. Typhimurium to evade the host´s innate 
immune response and to promote its own pathogenicity. Our previous results have 
demonstrated that S. Typhimurium exploits the host´s IFN-I response to promote RIP3-
dependent necroptosis in macrophages. Therefore, macrophages that lack the receptor for 
IFN-I (Ifnar1-/-) were less susceptible to S. Typhimurium-induced cell death than wildtype 
macrophages (Robinson et al. 2012). Importantly, macrophages subjected to IFN-I treatment 
without infection do not undergo cell death, indicating that during S. Typhimurium infection 
additional events combined with IFN-I signaling cumulate in necroptosis.  
Here, we investigated the IFN-I-mediated events that lead to necroptosis execution in 
S. Typhimurium-infected macrophages. We found that IFN-I signaling impairs Nrf2-
dependent anti-oxidative stress responses to S. Typhimurium infection, which results in ROS-
mediated mitochondrial dysfunction and subsequent cell death. We specifically show that 
S. Typhimurium-induced IFN-I activates RIP3, which promotes the expression of the 
mitochondrial phosphatase Pgam5 and its complex formation with Nrf2. Enhanced Pgam5-
Nrf2 interaction attenuates nuclear translocation of Nrf2 and the transcription of Nrf2-
dependent anti-oxidative genes. The impaired ability of macrophages to respond to 
S. Typhimurium-induced oxidative stress leads to ROS-mediated mitochondrial damage and 
energy depletion, which transiently triggers autophagy and reduces p62 levels. IFN-I perturbs 
the interaction of p62 with Keap1 thereby further downregulating Nrf2-dependent anti-
oxidative genes eventually sensitizing infected macrophages to cell death (Fig. 22).  
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Figure 22. IFN-I signaling exacerbates mitochondrial damage and cell death by preventing Nrf2-dependent 
antioxidant response. 
S. Typhimurium infection induces the para- and autocrine secretion of type I interferon (IFN-I), which subsequently 
binds to the IFN-I receptor (Ifnar1). In S. Typhimurium (S.T.)-infected macrophages, IFN-I induces RIP3-mediated 
Pgam5 expression. Pgam5 subsequently interacts with Nrf2 (presumably through Keap1), which sequesters Nrf2 
in the cytosol thereby repressing the transcription of Nrf2-dependent anti-oxidative genes. S. Typhimurium-
induced oxidative damage results in ROS-mediated mitochondrial dysfunction, energy depletion, transient 
induction of autophagy and autophagic degradation of p62. Reduced p62 levels impair interaction of p62 with 
Keap1, which further decreases Nrf2-dependent anti-oxidative responses to S. Typhimurium infection and 
sensitizes infected macrophages to cell death.   
Figure taken from (Hos et al. 2017). 
 
4.1.  IFN-I signaling exacerbates S. Typhimurium-induced mitochondrial dysfunction 
and oxidative stress  
Mitochondria are key organelles, which provide most of the cellular ATP, but have also 
been recognized as important mediators of innate immune signaling and programmed cell 
death (Chandel 2014; Wasilewski and Scorrano 2009; Weinberg et al. 2015). Therefore, 
disruption of mitochondrial integrity has been identified as a key virulence strategy of both 
viral and bacterial pathogens (Arnoult et al. 2009; Stavru et al. 2011). Here, we demonstrate 
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that S. Typhimurium infection causes mitochondrial damage in macrophages, which leads to 
mitochondrial ROS production and decreased ATP levels. In line with our findings, Hernandez 
and co-workers reported that S. Typhimurium disrupted mitochondrial function in a virulence-
dependent manner. Upon S. Typhimurium infection of macrophages, the SPI-1-encoded 
effector protein SipB translocated to mitochondria, which appeared swollen and devoid of 
christae, resulting in macrophage death (Hernandez et al. 2003). 
Although we did not specifically investigate virulence-dependent mechanisms of 
mitochondrial damage, we found that the host´s IFN-I response further exacerbated 
mitochondrial dysfunction. Our results indicate that IFN-I signaling during S. Typhimurium 
infection of macrophages further enhances mitochondrial ROS production and decreases 
cellular ATP levels due to the activation of RIP3, which represses the transcription of Nrf2-
dependent anti-oxidative enzymes. Although it is well accepted that mitochondrial DNA can 
engage the cGAS-STING cytosolic DNA sensing machinery to trigger IFN-I production (Li 
and Chen 2018), very little is known on how IFN-I signaling in turn regulates mitochondrial 
function. In a previous study by Lewis and co-workers IFN-I treatment of murine L929 and 
human Daudi lymphoblastoid cells decreased the expression of mitochondrial genes and 
cellular ATP levels. These authors concluded that functional impairment of the mitochondrial 
electron transport chain was responsible for the anti-proliferative effect mediated by IFN-I 
(Lewis et al. 1996). Although we cannot rule out that IFN-I signaling directly causes 
mitochondrial damage, our present results indicate that IFN-I signaling rather interferes with 
the expression of Nrf2-dependent detoxifying and protective enzymes thereby indirectly 
exacerbating S. Typhimurium-induced mitochondrial damage.  
4.2.  IFN-I signaling transiently triggers autophagy  
A decrease in cellular ATP leads to the activation of autophagy to maintain energy 
homeostasis (Mihaylova and Shaw 2011). In line with this notion, our results also demonstrate 
that S. Typhimurium infection transiently triggers autophagy in macrophages because of 
reduced ATP levels. By contrast, autophagy is triggered to a much lower extend in the 
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absence of IFN-I signaling, where ATP levels remain higher. Accordingly, recent work has 
shown that IFN-I treatment induced autophagy in multiple cancer cell lines. This effect was 
mediated by inhibition of mTORC1, a master regulator of autophagy (Schmeisser et al. 2013). 
In our study, however, autophagy is induced independent of mTORC1 inhibition, as mTORC1 
is activated shortly after S. Typhimurium infection. Furthermore, our results demonstrate that 
mTORC1 activation during S. Typhimurium infection occurs independent of IFN-I signaling.  
Likewise, a study by Owen and colleagues reported that mTORC1 was activated upon 
S. Typhimurium infection resulting in the blockade of autophagy (Owen et al. 2014). In line 
with this observation, we also found that autophagy is blocked at later stages of infection and 
that loss of IFN-I signaling further attenuates autophagy. Furthermore, recent studies have 
shown that S. Typhimurium was degraded along with autophagic cargo resulting in the 
enzymatic degradation of bacteria (Birmingham et al. 2006; Zheng et al. 2009). Blockade of 
autophagy could therefore be a strategy used by S. Typhimurium to prevent autophagic 
degradation. However, our results do not support this notion as bacterial numbers do not 
differ between WT macrophages, which show higher autophagic activity, compared to Ifnar1-
/-
 macrophages, in which autophagic flux was reduced. Accordingly, previous work from our 
group demonstrated that S. Typhimurium co-localized with LC3-positive structures only after 
one hour of infection, whereas S. Typhimurium escaped from these structures after four hours 
of infection (Ganesan et al. 2017). 
We have recently demonstrated that reduction of cellular ATP levels during 
S. Typhimurium infection resulted in activation of the cytoplasmic energy sensor AMPK, an 
important checkpoint of mTORC1 and autophagy. We found that S. Typhimurium targeted 
AMPK for lysosomal degradation in a SPI-2-dependent manner leading to the inhibition of 
autophagy and loss of energy (Ganesan et al. 2017). In addition, work from our group 
revealed that S. Typhimurium impairs glycolytic pathways thereby further limiting cellular 
energy resources (Gutiérrez et al., unpublished data). We therefore conclude that interfering 
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with cellular energy homeostasis is a key virulence strategy employed by S. Typhimurium to 
impair cell autonomous defense mechanisms and to promote its own intracellular survival.   
4.3 IFN-I signaling reduces p62 levels through autophagic degradation 
Inhibition of autophagy leads to the accumulation of p62-positive protein aggregates 
and cytosolic inclusion bodies, which is relevant to human disease (Komatsu et al. 2007; 
Zatloukal et al. 2002). For instance, p62-positive protein aggregates have been shown to play 
an important role in neurodegenerative disorders, such as Parkinson´s and Alzheimer´s 
disease (Hara et al. 2006; Komatsu et al. 2006; Rubinsztein 2006), chronic liver inflammation 
(Denk et al. 2006; Stumptner et al. 2007), and various cancer entities (Inami et al. 2011; 
Mathew et al. 2009; Thompson et al. 2003; Umemura et al. 2016). In this study, we found that 
p62 expression is also increased, both on mRNA and protein levels, upon S. Typhimurium 
infection of macrophages. Furthermore, we observed the formation of p62-containing protein 
aggregates in the perinuclear region of infected macrophages. Of note, IFN-I signaling 
reduces the number of p62-positive punctae through increased autophagolysosomal 
degradation of p62. Our finding that IFN-I signaling reduces p62 levels is supported by a 
recent study from Ejlerskov and colleagues, who also observed a strong accumulation of p62 
in IFN-β-deficient neuronal cells (Ejlerskov et al. 2015).  
While high p62 levels have mainly been considered as harmful upon chronic diseases, 
we found that accumulation of p62 in Ifnar1-/- macrophages is protective upon acute infection 
with S. Typhimurium. Our present results indicate that high p62 levels critically mediate 
survival of S. Typhimurium-infected macrophages, since knockdown of Sqstm1/p62 
significantly decreases macrophage viability. Similarly, p62 has previously been shown to 
mediate macrophage survival after pharmacological activation of the NLRP3 inflammasome 
(Zhong et al. 2016). In that study, p62 promoted clearance of damaged mitochondria through 
Parkin-mediated mitophagy thereby reducing mitochondrial ROS production and anti-
oxidative stress. Importantly, we also found that high p62 levels reduce S. Typhimurium-
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induced anti-oxidative stress through the increased transcription of Nrf2-dependent anti-
oxidative genes.  
4.4.  IFN-I signaling disrupts Nrf2-dependent anti-oxidative stress responses 
Beyond its function as an autophagic adaptor protein, p62 also plays an important role 
in regulating cellular redox homeostasis via its interference with the Nrf2-Keap1 pathway. The 
Nrf2-Keap1 pathway is a major regulator of anti-oxidative stress responses, and p62 is known 
to activate this pathway by suppressing Keap1-Nrf2 interaction in the cytosol. In the presence 
of high p62 levels, Keap1 displays higher binding affinity for p62 than for Nrf2 (Ichimura et al. 
2013). Hence, the transcription factor Nrf2 is released from Keap1, stabilized and 
translocated to the nucleus, where it induces the transcription of several anti-oxidative 
enzymes, such as Hmox-1, Nqo1 and Gclc, promoting cellular survival (Ichimura et al. 2013; 
Komatsu et al. 2010; Lau et al. 2010). The p62-Nrf2-Keap1 pathway has mainly been studied 
in the context of cancer pathogenesis, where high Nrf2 activity has been associated with poor 
prognosis as cancer cells were more resistant to chemotherapy induced anti-oxidative stress 
(Jaramillo and Zhang 2013; Umemura et al. 2016).  
Here, we demonstrate that the p62-Nrf2-Keap1 pathway is also important for cell 
autonomous immune defenses against S. Typhimurium and that the host´s IFN-I response 
negatively regulates this pathway by decreasing p62 levels. We found that IFN-I signaling 
reduces the expression and nuclear translocation of Nrf2 in S. Typhimurium-infected 
macrophages, which impairs the transcription of the Nrf2-dependent anti-oxidative enzymes 
Hmox-1, Nqo1 and Gclc. Our results indicate that IFN-I signaling mediates Nrf2 degradation 
(presumably through the proteasomal pathway) rather than reducing Nrf2 transcription as 
IFN-I signaling increases mRNA expression of Nrf2 in S. Typhimurium-infected 
macrophages. Our observation that Nrf2 expression is regulated post-transcriptionally is in 
agreement with previous findings demonstrating that Keap1 mediated the ubiquitination and 
subsequent proteasomal degradation of Nrf2 (Kobayashi et al. 2004).  
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While there are very few studies investigating the importance of the p62-Nrf2-Keap1 
pathway upon bacterial infection, a role for Nrf2 in regulating anti-oxidative stress responses 
has recently been demonstrated for viral infection (Olagnier et al. 2014). In accordance with 
our findings, the expression of Nrf2-dependent target genes limited ROS production during 
Dengue virus infection of dendritic cells, whereas genetic silencing of Nrf2 enhanced ROS 
production and Dengue-induced cell death. Furthermore, genetic silencing of Nrf2 increased 
IFN-β mRNA expression upon Dengue virus infection. In that particular study, however, the 
effect of IFN-β on regulating Nrf2-dependent redox homeostasis or cell death has not been 
addressed.  
In one of the few studies investigating the role of the p62-Nrf2-Keap1 pathways during 
bacterial infection, Ichimura and colleagues reported that S. Typhimurium infection enhanced 
the expression of Nrf2-dependent cytoprotective genes in mouse embryonic fibroblasts 
(MEFs) (Ichimura et al. 2013). Apart from Hmox-1, however, we did not observe that 
S. Typhimurium infection induces a significant upregulation of anti-oxidant genes in WT 
macrophages. In our study, the transcription of Nrf2-dependent anti-oxidative genes is only 
enhanced in the absence of IFN-I signaling, indicating that IFN-I negatively regulates anti-
oxidative stress responses. Another report from the same group suggested that 
S. Typhimurium activated the Keap1-Nrf2 system through phosphorylation of p62 at Ser351 
during xenophagy (Ishimura et al. 2014). Accordingly, we found that S. Typhimurium infection 
induces p62 expression and interaction of p62 with Keap1 in macrophages. However, in the 
presence of IFN-I signaling the interaction of p62 with Keap1 is not sufficient to promote Nrf2-
dependent cytoprotective responses. By contrast, loss of IFN-I signaling strongly enhances 
the interaction of p62 with Keap1 and increases Nrf2-dependent anti-oxidative stress 
responses to S. Typhimurium infection. Discrepancies to the results reported by Ishimura et 
al. could be attributed to the different cell types investigated, as the response to IFN-I during 
S. Typhimurium infection might differ in MEFs and BMDMs. 
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Similar to Ifnar1-/- macrophages, we observed high p62 levels in autophagy-deficient 
Atg7-/- macrophages after infection with S. Typhimurium. Despite p62 accumulation, however, 
autophagy deficiency does not result in enhanced macrophage survival. Accordingly, recent 
studies have demonstrated that autophagy defects sensitize cells to inflammatory cell death 
(Yonekawa and Thorburn 2013). Importantly, we found that blockade of IFN-I signaling 
significantly increases survival of S. Typhimurium-infected Atg7-/- macrophages through the 
upregulation of Nrf2-dependent anti-oxidative genes.  
Although our results suggest that p62 contributes to the regulation of Nrf2-dependent 
redox homeostasis and macrophage viability upon S. Typhimurium infection, we conclude 
that additional pathways besides p62 must be involved in regulating IFN-I-induced cell death.   
4.5 S. Typhimurium infection activates Pgam5 downstream of IFN-I/RIP3 
Previous studies have indicated that the expression of Nrf2-dependent genes was 
additionally regulated by the mitochondrial phosphatase Pgam5. Upon oxidative stress, 
Pgam5 was targeted to the outer membrane of mitochondria, where it formed a ternary 
complex with Nrf2 and Keap1. In this complex, dimeric Keap1 simultaneously bound both 
Pgam5 and Nrf2 (Lo and Hannink 2008). Importantly, knockdown of Pgam5 activated Nrf2-
dependent ARE gene expression in Hela cells, indicating that Pgam5 is a negative regulator 
of antioxidant stress responses (Lo and Hannink 2008). In accordance with these findings, 
we demonstrate that Pgam5 is highly expressed in S. Typhimurium-infected macrophages 
and that Pgam5 negatively regulates Nrf2-dependent gene expression. Importantly, IFN-I 
signaling increases Pgam5 expression and enhances the interaction of Nrf2 with Pgam5 
(presumably through Keap1) thereby impairing Nrf2 function.  
Beyond regulating anti-oxidant stress responses, Pgam5 has also been reported to 
mediate RIP1/3-dependent necroptosis. Upon TNF receptor activation, Pgam5 formed a 
mitochondrial complex with RIP1- and RIP3 leading to Drp1-mediated mitochondrial 
fragmentation, a crucial step for necroptosis induction (Wang et al. 2012). Our present results 
indicate that during S. Typhimurium infection IFN-I activates RIP3, which induces expression 
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of Pgam5. In agreement with our observation that IFN-I signaling promotes Nrf2-Pgam5 
complex formation, also the activation of the IFN-I downstream target RIP3 enhances the 
interaction of Nrf2 with Pgam5. Consequently, Pgam5 sequesters Nrf2 in the cytosol, which 
impairs the anti-oxidative stress response against S. Typhimurium.  
4.6  S. Typhimurium infection induces cell death through impaired Nrf2 function 
Over the last decades, considerable work has focused on S. Typhimurium-induced 
cell death of macrophages and multiple cell death pathways including caspase-1 and 
caspase-11-mediated pyroptosis (Man et al. 2017; Thurston et al. 2016) and RIP1/RIP3-
mediated necroptosis (Robinson et al. 2012) have been identified. In our previous work we 
have demonstrated that IFN-I mediated the recruitment of RIP3 to the IFN-I receptor of 
S. Typhimurium-infected macrophages, which resulted in necroptosis execution (Robinson et 
al. 2012). Our present results indicate that IFN-I signaling impairs the ability of macrophages 
to respond to S. Typhimurium-induced oxidative stress by interfering with Nrf2 activation 
through decreased p62 and increased Pgam5 expression. The inability to respond to 
S. Typhimurium-induced damage finally results in macrophage death. 
Our observation that pharmacological activation of Nrf2 protects macrophages from 
S. Typhimurium-induced cell death by limiting ROS production is in agreement with previous 
studies demonstrating an anti-oxidative, cytoprotective effect of Nrf2 enhancers (Liby et al. 
2005; Yang et al. 2009). Importantly, we found that pharmacological activation of Nrf2 only 
prevents cell death of WT macrophages, whereas it has no additional effect in IFN-I deficient 
macrophages, where Nrf2 target genes are already highly upregulated. Consequently, we 
found that scavenging of mitochondrial ROS promotes macrophages survival after infection 
with S. Typhimurium.   
Furthermore, our results demonstrate that IFN-I-regulated cell death is not a 
consequence of increased caspase-1 activation and subsequent pyroptosis, since IFN-I 
signaling reduces IL-1β secretion after S. Typhimurium infection. However, it remains to be 
investigated if caspase-11 is an additional player in IFN-I-regulated necroptosis in 
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S. Typhimurium-infected macrophages as IFN-I-induced GTPases are known to regulate 
caspase-11 activation (Meunier et al. 2014). 
 
CONCLUSION 
In conclusion, we have unraveled that the host´s IFN-I response exacerbates 
mitochondrial dysfunction upon S. Typhimurium infection of macrophages and that perturbed 
cellular redox homeostasis precedes S. Typhimurium-induced cell death.  We propose a 
model, in which IFN-I/RIP3 signaling diminishes Nrf2-mediated anti-oxidative stress 
responses to S. Typhimurium infection through enhanced interaction of Nrf2 with Pgam5 
(Fig. 22). The reduced ability to respond to S. Typhimurium-induced oxidative stress results 
in ROS-mediated mitochondrial damage, energy depletion and transient induction of 
autophagy. Autophagy post-transcriptionally downregulates p62 leading to perturbed p62-
Keap1 interaction, which further represses Nrf2 function and eventually sensitizes 
macrophages to S. Typhimurium-induced necroptosis.  
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FUTURE PERSPECTIVES 
Over the last decades, an alarming number of bacterial pathogens, particularly Gram-
negative bacteria, has become resistant to standard antibiotic treatment. For some infections 
caused by multi-resistant bacteria even reserve antibiotics are no longer effective, which 
dramatically has increased morbidity and mortality rates. Host-directed therapies that 
modulate the patient´s immune response, rather than targeting the pathogen itself, could 
therefore be a novel treatment approach in the post-antibiotic era.   
Our findings imply that inhibition of the host´s IFN-I signaling pathways could provide 
a therapeutic option for the supportive treatment of S. Typhimurium infection. Furthermore, 
we report here that increasing the Nrf2-dependent anti-oxidative response using 
pharmacological Nrf2 activators significantly improves infection outcome. Pharmacological 
interference with IFN-I signaling and Nrf2-dependent anti-oxidative responses might therefore 
be a novel treatment approach to combat Gram-negative infections in the future. Further 
studies are needed, however, to investigate whether our findings are transferable to infections 
caused by other Gram-negative or Gram-positive bacteria. 
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